<?xml version="1.0" encoding="UTF-8"?>
<drug type="small molecule" created="2007-06-30" updated="2020-01-02">
  <drugbank-id primary="true">DB01294</drugbank-id>
  <drugbank-id>DB01402</drugbank-id>
  <name>Bismuth subsalicylate</name>
  <description>Bismuth subsalicylate is the active ingredient in the popular medication Pepto-Bismol that is used to treat nausea, heartburn, indigestion, upset stomach, diarrhea, and other temporary discomforts of the stomach and gastrointestinal tract. It is also the main ingredient of Kaopectate. It displays anti-inflammatory action (due to salicylic acid) and also acts as an antacid and mild antibiotic.</description>
  <cas-number>14882-18-9</cas-number>
  <unii>62TEY51RR1</unii>
  <average-mass>362.0926</average-mass>
  <monoisotopic-mass>361.999166889</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>approved</group>
    <group>vet_approved</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <ref-id>A2350</ref-id>
        <pubmed-id>1158081</pubmed-id>
        <citation>Goldenberg MM, Honkomp LJ, Burrous SE, Castellion AW: Protective effect of Pepto-Bismol liquid on the gastric mucosa of rats. Gastroenterology. 1975 Sep;69(3):636-40.</citation>
      </article>
    </articles>
    <textbooks/>
    <links/>
    <attachments/>
  </general-references>
  <synthesis-reference>Richard William Hess, "Pigmentary bright primrose yellow monoclinic bismuth vanadate and processes for the preparation thereof." U.S. Patent US4115142, issued December, 1925.</synthesis-reference>
  <indication>Used to treat nausea, heartburn, indigestion, upset stomach, diarrhea, and other temporary discomforts of the stomach and gastrointestinal tract.</indication>
  <pharmacodynamics>Bismuth subsalicylate displays anti-inflammatory action (due to salicylic acid) and also acts as an antacid and mild antibiotic. It can also cause a black tongue and black stools in some users of the drug, when it combines with trace amounts of sulfur in their saliva and gastrointestinal tract. This discoloration is temporary and harmless.</pharmacodynamics>
  <mechanism-of-action>As an antidiarrheal, the exact mechanism has not been determined. Bismuth subsalicylate may exert its antidiarrheal action not only by stimulating absorption of fluid and electrolytes across the intestinal wall (antisecretory action) but also, when hydrolyzed to salicylic acid, by inhibiting synthesis of a prostaglandin responsible for intestinal inflammation and hypermotility. In addition, bismuth subsalicylate binds toxins produced by Escherichia coli. Both bismuth subsalicylate and the intestinal reaction products, bismuth oxychloride and bismuth hydroxide, are believed to have bactericidal action. As an antacid, bismuth has weak antacid properties.</mechanism-of-action>
  <toxicity/>
  <metabolism>Based on in vitro dissociation data and in vivo animal data, bismuth subsalicylate is believed to be largely hydrolyzed in the stomach to bismuth oxychloride and salicylic acid. In the small intestine, nondissociated bismuth subsalicylate reacts with other anions (bicarbonate and phosphate) to form insoluble bismuth salts. In the colon, nondissociated bismuth subsalicylate and other bismuth salts react with hydrogen sulfide to produce bismuth sulfide, a highly insoluble black salt responsible for the darkening of the stools.</metabolism>
  <absorption>Following oral administration, absorption of the salicylate component from the small intestine is generally rapid and complete (&gt;90%). </absorption>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description>This compound belongs to the class of organic compounds known as benzenoids. These are aromatic compounds containing one or more benzene rings.</description>
    <direct-parent>Benzenoids</direct-parent>
    <kingdom>Organic compounds</kingdom>
    <superclass>Benzenoids</superclass>
    <class/>
    <subclass/>
    <alternative-parent>Carboxylic acid salts</alternative-parent>
    <alternative-parent>Hydrocarbon derivatives</alternative-parent>
    <alternative-parent>Metalloheterocyclic compounds</alternative-parent>
    <alternative-parent>Monocarboxylic acids and derivatives</alternative-parent>
    <alternative-parent>Organic metal salts</alternative-parent>
    <alternative-parent>Organic oxides</alternative-parent>
    <alternative-parent>Organooxygen compounds</alternative-parent>
    <alternative-parent>Oxacyclic compounds</alternative-parent>
    <substituent>Aromatic heteropolycyclic compound</substituent>
    <substituent>Benzenoid</substituent>
    <substituent>Carboxylic acid derivative</substituent>
    <substituent>Carboxylic acid salt</substituent>
    <substituent>Hydrocarbon derivative</substituent>
    <substituent>Metalloheterocycle</substituent>
    <substituent>Monocarboxylic acid or derivatives</substituent>
    <substituent>Organic metal salt</substituent>
    <substituent>Organic oxide</substituent>
    <substituent>Organic oxygen compound</substituent>
    <substituent>Organic salt</substituent>
    <substituent>Organoheterocyclic compound</substituent>
    <substituent>Organooxygen compound</substituent>
    <substituent>Oxacycle</substituent>
  </classification>
  <salts/>
  <synonyms>
    <synonym language="english" coder="">2-Hydroxy-benzo[1,3,2]dioxabismin-4-one</synonym>
    <synonym language="english" coder="">Basic bismuth salicylate</synonym>
    <synonym language="english" coder="">Bismuth oxide salicylate</synonym>
    <synonym language="english" coder="">Bismuth oxysalicylate</synonym>
    <synonym language="english" coder="usan">Bismuth Subsalicylate</synonym>
    <synonym language="english" coder="">Pink bismuth</synonym>
    <synonym language="english" coder="">Wismutsubsalicylat</synonym>
  </synonyms>
  <products>
    <product>
      <name>7 Select Pink Bismuth</name>
      <labeller>7-Eleven</labeller>
      <ndc-id/>
      <ndc-product-code>10202-337</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-04-17</started-marketing-on>
      <ended-marketing-on>2019-10-31</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>7-Select Pepto Bismol</name>
      <labeller>Lil' Drug Store Products, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>66715-9823</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-08-01</started-marketing-on>
      <ended-marketing-on>2017-12-31</ended-marketing-on>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Anti-Diarrheal</name>
      <labeller>Lil' Drug Store Products, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>66715-6841</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-02-21</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Basic Care Stomach Relief</name>
      <labeller>L. Perrigo Company</labeller>
      <ndc-id/>
      <ndc-product-code>0113-7469</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-01-11</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Being Well stomach relief original strength</name>
      <labeller>Save A Lot Food Stores, Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code>46994-302</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2006-02-25</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Bismatrol</name>
      <labeller>Aidarex Pharmaceuticals LLC</labeller>
      <ndc-id/>
      <ndc-product-code>53217-058</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2003-01-03</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Bismatrol</name>
      <labeller>Aidarex Pharmaceuticals LLC</labeller>
      <ndc-id/>
      <ndc-product-code>53217-060</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2008-05-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Bismatrol</name>
      <labeller>Preferred Pharmaceuticals Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>68788-7140</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-04-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Bismatrol</name>
      <labeller>Atlantic Biologicals Corps</labeller>
      <ndc-id/>
      <ndc-product-code>17856-1313</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2008-05-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Bismatrol</name>
      <labeller>Proficient Rx LP</labeller>
      <ndc-id/>
      <ndc-product-code>63187-650</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2003-01-03</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Bismatrol</name>
      <labeller>Proficient Rx LP</labeller>
      <ndc-id/>
      <ndc-product-code>63187-651</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2008-05-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Bismatrol</name>
      <labeller>Major Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>0904-1315</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2003-01-03</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Bismatrol</name>
      <labeller>Major Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>0904-1314</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-01-05</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Bismatrol</name>
      <labeller>Major Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>0904-1313</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2008-05-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Bismed Chewable Tablets</name>
      <labeller>Technilab Pharma Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00810509</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>1998-09-14</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Bismed Liq 17.66mg/ml</name>
      <labeller>Technilab Pharma Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02045354</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1994-12-31</started-marketing-on>
      <ended-marketing-on>2005-08-05</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Bismol</name>
      <labeller>SAMSUNG PHARM. IND.CO.,LTD.</labeller>
      <ndc-id/>
      <ndc-product-code>49789-080</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-02-01</started-marketing-on>
      <ended-marketing-on>2016-12-01</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength>262 mg/434mg</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Bismuth</name>
      <labeller>Rij Pharmaceutical Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>53807-152</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1999-03-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Bismuth</name>
      <labeller>Allegiant Health</labeller>
      <ndc-id/>
      <ndc-product-code>69168-046</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-12-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Bismuth</name>
      <labeller>Perrigo International</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02220709</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1998-04-08</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>17.6 mg</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Bismuth</name>
      <labeller>Pharmetics (2011) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02314312</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-02-04</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>262 mg</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Bismuth</name>
      <labeller>Pharmalab Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02310791</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>262 mg</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Bismuth</name>
      <labeller>Actavis Pharma Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02428385</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>17.5 mg</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Bismuth (cherry Flavour)</name>
      <labeller>Arrow Otc Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02296330</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2008-01-02</started-marketing-on>
      <ended-marketing-on>2012-07-24</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Bismuth (original Formula)</name>
      <labeller>Arrow Otc Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02296322</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2008-01-02</started-marketing-on>
      <ended-marketing-on>2011-08-03</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Bismuth + Antacid (chewable Tablets)</name>
      <labeller>Perrigo International</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02240473</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2000-09-27</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Bismuth Caplets</name>
      <labeller>Vita Health Products Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02243123</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2001-04-01</started-marketing-on>
      <ended-marketing-on>2002-07-31</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Bismuth Caplets</name>
      <labeller>Tanta Pharmaceuticals Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02280019</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Bismuth Caplets</name>
      <labeller>Juno Otc Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02457121</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-09-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Bismuth Caplets</name>
      <labeller>Jamp Pharma Corporation</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02245730</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2004-06-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Bismuth Caplets</name>
      <labeller>TEVA Canada Limited</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02418584</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-08-25</started-marketing-on>
      <ended-marketing-on>2019-07-12</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Bismuth Chewable</name>
      <labeller>Marc Glassman, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>68998-046</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2003-04-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Bismuth Chewable Tablets</name>
      <labeller>Vita Health Products Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02243124</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2001-04-01</started-marketing-on>
      <ended-marketing-on>2004-07-26</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Bismuth Chewables</name>
      <labeller>Jamp Pharma Corporation</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02245731</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2003-10-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Bismuth Chewables</name>
      <labeller>TEVA Canada Limited</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02418592</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-09-09</started-marketing-on>
      <ended-marketing-on>2019-07-09</ended-marketing-on>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Bismuth Liq 17.6mg/ml</name>
      <labeller>Technilab Pharma Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00807060</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1990-12-31</started-marketing-on>
      <ended-marketing-on>1997-08-22</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Bismuth Liquid</name>
      <labeller>Tanta Pharmaceuticals Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02280000</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Bismuth Liquid</name>
      <labeller>Supplements Aromatik Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02283441</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Bismuth Maximum Strength</name>
      <labeller>Dolgencorp, Inc. (Dollar General &amp; Rexall)</labeller>
      <ndc-id/>
      <ndc-product-code>55910-682</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-07-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Bismuth subsalicylate</name>
      <labeller>Rugby</labeller>
      <ndc-id/>
      <ndc-product-code>0536-4301</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-01-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Bismuth Subsalicylate</name>
      <labeller>A&amp;Z Pharmaceutical, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>62211-046</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2003-03-10</started-marketing-on>
      <ended-marketing-on>2015-05-04</ended-marketing-on>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Bismuth Subsalicylate</name>
      <labeller>CVS Pharmacy, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>69842-346</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-07-06</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, film coated</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Bismuth subsalicylate</name>
      <labeller>Nucare Pharmaceuticals,inc.</labeller>
      <ndc-id/>
      <ndc-product-code>68071-4523</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Bismuth Subsalicylate</name>
      <labeller>Lohxa</labeller>
      <ndc-id/>
      <ndc-product-code>70166-059</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2008-05-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Bismuth Subsalicylate</name>
      <labeller>Lil' Drug Store Products, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02401479</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-11-12</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>262 mg</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Bismuth Subsalicylate 262 mg</name>
      <labeller>Reliable 1 Laboratories LLC</labeller>
      <ndc-id/>
      <ndc-product-code>69618-029</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-11-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Bismuth Subsalicylate Caplets</name>
      <labeller>Guardian Drug Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02326582</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-02-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Bismuth Subsalicylate Liquid</name>
      <labeller>Guardian Drug Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02313162</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2008-12-12</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Bismuth Subsalicylate Liquid</name>
      <labeller>Pharmetics (2011) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02338408</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Bismuth Subsalicylate Liquid Extra Strength</name>
      <labeller>Pharmetics (2011) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02353989</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Bismuth Subsalicylate Liquid Extra Strength</name>
      <labeller>Crls</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02449307</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Bismuth Subsalicylate Maximum Strength Stomach Relief</name>
      <labeller>Aurohealth LLC</labeller>
      <ndc-id/>
      <ndc-product-code>58602-519</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-09-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Bismuth Subsalicylate Maximum Strength Stomach Relief</name>
      <labeller>Aurohealth LLC</labeller>
      <ndc-id/>
      <ndc-product-code>58602-300</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-12-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Bismuth Subsalicylate Suspension 17.6mg/ml</name>
      <labeller>Stanley Pharmaceuticals, A Division Of Vita Health Products Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00876526</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1992-12-31</started-marketing-on>
      <ended-marketing-on>2002-07-31</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Bismuth Subsalicylate Suspension 17.6mg/ml</name>
      <labeller>Wes Pak Products Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02035278</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2000-08-04</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Bismuth Subsalicylate/Metronidazole/Tetracycline Hydrochloride</name>
      <labeller>Ailex Pharmaceuticals, Llc</labeller>
      <ndc-id/>
      <ndc-product-code>70556-103</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-11-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Oral</route>
      <fda-application-number>ANDA202584</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Bismuth Tablets With Calcium Carbonate</name>
      <labeller>Tanta Pharmaceuticals Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02317117</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Bismuth Tabs</name>
      <labeller>Dolgencorp</labeller>
      <ndc-id/>
      <ndc-product-code>55910-756</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1998-07-16</started-marketing-on>
      <ended-marketing-on>2016-06-26</ended-marketing-on>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Bismutina</name>
      <labeller>Menper Distributors</labeller>
      <ndc-id/>
      <ndc-product-code>53145-055</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-02-21</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Bismylate-bismuth Subsalicylate Sus 17.6gm/ml</name>
      <labeller>Stanley Pharmaceuticals, A Division Of Vita Health Products Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02240410</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1990-12-31</started-marketing-on>
      <ended-marketing-on>2002-07-31</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Careone Stomach Relief</name>
      <labeller>American Sales Company</labeller>
      <ndc-id/>
      <ndc-product-code>41520-302</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-08-05</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Careone Stomach Relief</name>
      <labeller>American Sales Company</labeller>
      <ndc-id/>
      <ndc-product-code>41520-337</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-08-05</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cherry Flavour Pepto-bismol Tab</name>
      <labeller>Procter And Gamble</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01983725</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1992-12-31</started-marketing-on>
      <ended-marketing-on>1997-10-31</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Chewable</name>
      <labeller>Publix Supermarkets, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>56062-469</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2001-03-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Chewable Bismuth Tablets With Calcium Carbonate</name>
      <labeller>Pharmetics (2011) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02319888</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-09-24</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Chewable Stomach Relief</name>
      <labeller>Publix Super Markets Inc,</labeller>
      <ndc-id/>
      <ndc-product-code>41415-124</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-06-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Circle K Stomach</name>
      <labeller>Lil' Drug Store Products, Inc</labeller>
      <ndc-id/>
      <ndc-product-code>66715-5755</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-10-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>CVS Health Anti-Diarrheal Vanilla</name>
      <labeller>CVS Pharmacy,Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>59779-883</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-08-11</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>CVS Health Stomach relief Cherry Flavor</name>
      <labeller>CVS Pharmacy,Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>69842-221</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-03-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Desempacho Cucharadas</name>
      <labeller>Pharmalab Enterprises Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>14505-400</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-01-09</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Dg Health Stomach Relief Maximum Strength</name>
      <labeller>Dolgencorp</labeller>
      <ndc-id/>
      <ndc-product-code>55910-800</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-09-09</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Digestive Relief Regular Strength</name>
      <labeller>Being Well</labeller>
      <ndc-id/>
      <ndc-product-code>46994-372</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-08-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Digestive Relief Regular Strength</name>
      <labeller>Being Well</labeller>
      <ndc-id/>
      <ndc-product-code>46994-724</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-09-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Digestive Relief Regular Strength</name>
      <labeller>TARGET Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>11673-724</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-09-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Digestive Relief Regular Strength</name>
      <labeller>TARGET Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>11673-372</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-09-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Equaline Maximum Strength Stomach Relief</name>
      <labeller>SUPERVALU INC.</labeller>
      <ndc-id/>
      <ndc-product-code>41163-937</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-09-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Equaline Stomach Relief</name>
      <labeller>Supervalu</labeller>
      <ndc-id/>
      <ndc-product-code>41163-600</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2004-10-07</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Equaline Stomach Relief</name>
      <labeller>Supervalu</labeller>
      <ndc-id/>
      <ndc-product-code>41163-146</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2004-10-14</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Equaline Stomach Relief</name>
      <labeller>SUPERVALU INC.</labeller>
      <ndc-id/>
      <ndc-product-code>41163-936</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-09-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Equate Stomach Relief</name>
      <labeller>Wal-Mart Stores, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>49035-122</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-05-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>equate stomach relief Maximum Strength</name>
      <labeller>Walmart Stores</labeller>
      <ndc-id/>
      <ndc-product-code>49035-337</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2001-02-02</started-marketing-on>
      <ended-marketing-on>2016-07-01</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Equate Stomach Relief Regular Strength</name>
      <labeller>Walmart Stores</labeller>
      <ndc-id/>
      <ndc-product-code>49035-302</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1989-12-15</started-marketing-on>
      <ended-marketing-on>2013-01-14</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Estomaquil Polvo</name>
      <labeller>ProMex LLC</labeller>
      <ndc-id/>
      <ndc-product-code>58988-1080</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2004-01-02</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Powder</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Estomax</name>
      <labeller>Pharmadel LLC</labeller>
      <ndc-id/>
      <ndc-product-code>55758-305</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-02-21</started-marketing-on>
      <ended-marketing-on>2018-04-17</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Extra Strength Bismuth</name>
      <labeller>Actavis Pharma Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02419262</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Extra Strength Bismuth</name>
      <labeller>Jamp Pharma Corporation</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02247094</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2004-06-24</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Extra Strength Bismuth</name>
      <labeller>Juno Otc Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02475855</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Extra Strength Bismuth Subsalicylate Liquid</name>
      <labeller>Guardian Drug Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02328453</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-07-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Extra-strength Bismuth</name>
      <labeller>Perrigo International</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02242537</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2000-11-21</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Family Care Stomach Relief</name>
      <labeller>United Exchange Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>65923-626</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-07-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Flanadol Pronto Bismuth</name>
      <labeller>Jomex International Llc</labeller>
      <ndc-id/>
      <ndc-product-code>69458-713</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2016-04-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Gastrobiz</name>
      <labeller>Allegiant Health</labeller>
      <ndc-id/>
      <ndc-product-code>69168-999</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-07-04</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Geri-pectate Peppermint Flavor</name>
      <labeller>Geri-Care Pharmaceuticals, Corp</labeller>
      <ndc-id/>
      <ndc-product-code>57896-396</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2000-01-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Geri-pectate Vanilla Flavor</name>
      <labeller>Geri-Care Pharmaceuticals, Corp</labeller>
      <ndc-id/>
      <ndc-product-code>57896-391</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2000-01-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>GNP Pink Bismuth</name>
      <labeller>Amerisource Bergen</labeller>
      <ndc-id/>
      <ndc-product-code>24385-017</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-08-08</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>GNP Pink Bismuth</name>
      <labeller>Amerisource Bergen</labeller>
      <ndc-id/>
      <ndc-product-code>24385-024</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-07-07</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Good Sense Stomach Relief</name>
      <labeller>L. Perrigo Company</labeller>
      <ndc-id/>
      <ndc-product-code>0113-0469</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1993-08-24</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Good Sense Stomach Relief</name>
      <labeller>L. Perrigo Company</labeller>
      <ndc-id/>
      <ndc-product-code>0113-0337</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1990-01-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Good Sense Stomach Relief original strength</name>
      <labeller>L. Perrigo Company</labeller>
      <ndc-id/>
      <ndc-product-code>0113-0302</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1989-09-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Green Relief</name>
      <labeller>Green Choice for Life</labeller>
      <ndc-id/>
      <ndc-product-code>55287-102</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-02-21</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Health Mart Stomach Relief</name>
      <labeller>Strategic Sourcing Services LLC</labeller>
      <ndc-id/>
      <ndc-product-code>62011-0278</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2016-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Health Mart Stomach Relief</name>
      <labeller>Strategic Sourcing Services LLC</labeller>
      <ndc-id/>
      <ndc-product-code>62011-0279</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2016-03-13</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Health Mart Stomach relief</name>
      <labeller>Strategic Sourcing Services LLC</labeller>
      <ndc-id/>
      <ndc-product-code>62011-0140</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-10-17</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Healthy Accents Stomach Relief</name>
      <labeller>Dza Brands,</labeller>
      <ndc-id/>
      <ndc-product-code>55316-337</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2008-01-22</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Healthy Accents Stomach Relief</name>
      <labeller>Dza Brands,</labeller>
      <ndc-id/>
      <ndc-product-code>55316-469</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-01-02</started-marketing-on>
      <ended-marketing-on>2012-05-01</ended-marketing-on>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Healthy Accents Stomach Relief</name>
      <labeller>Dza Brands,</labeller>
      <ndc-id/>
      <ndc-product-code>55316-084</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-02-07</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Healthy Accents Stomach Relief Original Strength</name>
      <labeller>Dza Brands,</labeller>
      <ndc-id/>
      <ndc-product-code>55316-302</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2008-01-22</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>HEB Diarrhea Relief Vanilla Flavor</name>
      <labeller>HEB</labeller>
      <ndc-id/>
      <ndc-product-code>37808-173</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-05-14</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>HEB Stomach Relief</name>
      <labeller>H E B</labeller>
      <ndc-id/>
      <ndc-product-code>37808-152</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-09-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>HEB Stomach Relief</name>
      <labeller>H E B</labeller>
      <ndc-id/>
      <ndc-product-code>37808-147</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-09-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>HEB Stomach Relief Cherry</name>
      <labeller>H E B</labeller>
      <ndc-id/>
      <ndc-product-code>37808-148</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-09-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>HEB Stomach Relief Max Strength</name>
      <labeller>HEB</labeller>
      <ndc-id/>
      <ndc-product-code>37808-770</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-04-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>HEB Stomach Relief Regular Strength</name>
      <labeller>H E B</labeller>
      <ndc-id/>
      <ndc-product-code>37808-607</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-03-07</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>HELIDAC Therapy</name>
      <labeller>Prometheus Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>65483-495</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-08-15</started-marketing-on>
      <ended-marketing-on>2014-02-01</ended-marketing-on>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>NDA050719</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Ka Pec</name>
      <labeller>Rij Pharmaceutical Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>53807-515</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1999-03-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Kao-Bis</name>
      <labeller>Rij Pharmaceutical Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>53807-503</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1999-03-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Kao-tin Peppermint Flavor</name>
      <labeller>MAJOR Pharmaceuticals Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0904-5709</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-02-14</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Kaopectate</name>
      <labeller>Chattem, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>41167-4002</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-04-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Kaopectate Extra Strength Peppermint Flavor Anti Diarrheal</name>
      <labeller>Chattem, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>41167-7449</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2003-04-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>35.0 mg/1mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Kaopectate Regular Strength Cherry Flavor</name>
      <labeller>Chattem, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>41167-6050</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2004-04-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Kaopectate Regular Strength Peppermint Flavor Anti Diarrheal</name>
      <labeller>Chattem, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>41167-3330</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2003-04-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>17.47 mg/1mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Kaopectate Regular Strength Vanilla Flavor Anti Diarrheal</name>
      <labeller>Physicians Total Care, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>54868-2298</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2008-05-12</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Kaopectate Regular Strength Vanilla Flavor Anti Diarrheal</name>
      <labeller>A-S Medication Solutions</labeller>
      <ndc-id/>
      <ndc-product-code>50090-4467</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2003-04-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Kaopectate Regular Strength Vanilla Flavor Anti Diarrheal</name>
      <labeller>Chattem, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>41167-4000</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2003-04-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Kola-Pectin DS</name>
      <labeller>Seyer Pharmatec, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>11026-2639</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-10-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Leader Maximum Strength Stomach Relief</name>
      <labeller>Cardinal Health</labeller>
      <ndc-id/>
      <ndc-product-code>70000-0440</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-07-25</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Leader Stomach Relief</name>
      <labeller>Cardinal Health</labeller>
      <ndc-id/>
      <ndc-product-code>37205-951</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1990-04-15</started-marketing-on>
      <ended-marketing-on>2016-06-16</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Leader Stomach Relief</name>
      <labeller>Cardinal Health</labeller>
      <ndc-id/>
      <ndc-product-code>37205-952</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1994-11-09</started-marketing-on>
      <ended-marketing-on>2015-09-23</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Leader stomach relief</name>
      <labeller>Cardinal Health</labeller>
      <ndc-id/>
      <ndc-product-code>70000-0354</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-02-05</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Leader Stomach Relief</name>
      <labeller>Cardinal Health</labeller>
      <ndc-id/>
      <ndc-product-code>70000-0355</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-02-02</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Leader Stomach Relief</name>
      <labeller>Cardinal Health</labeller>
      <ndc-id/>
      <ndc-product-code>49781-025</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1990-04-15</started-marketing-on>
      <ended-marketing-on>2019-11-30</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Leader Stomach Relief</name>
      <labeller>Cardinal Health</labeller>
      <ndc-id/>
      <ndc-product-code>49781-050</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-02-20</started-marketing-on>
      <ended-marketing-on>2019-10-31</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Leader Stomach Relief</name>
      <labeller>Cardinal Health</labeller>
      <ndc-id/>
      <ndc-product-code>70000-0433</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-06-06</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Leader Stomach Relief</name>
      <labeller>Cardinal Health</labeller>
      <ndc-id/>
      <ndc-product-code>70000-0439</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-06-07</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Leader Stomach Relief original strength</name>
      <labeller>Cardinal Health</labeller>
      <ndc-id/>
      <ndc-product-code>37205-720</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-08-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Maximum Strength</name>
      <labeller>Publix Supermarkets, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>56062-337</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2002-08-08</started-marketing-on>
      <ended-marketing-on>2013-05-26</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Maximum strength Stomach Relief</name>
      <labeller>Winco Foods</labeller>
      <ndc-id/>
      <ndc-product-code>67091-234</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-12-12</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Maximum strength Stomach Relief</name>
      <labeller>CVS Health</labeller>
      <ndc-id/>
      <ndc-product-code>69842-528</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2008-09-08</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Maximum Strength Stomach Relief</name>
      <labeller>Harris Teeter</labeller>
      <ndc-id/>
      <ndc-product-code>72036-007</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-04-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Mcneil Stomach Relief</name>
      <labeller>Mcneil Consumer Healthcare Division Of Johnson &amp; Johnson Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02275775</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Medi-First Pep-T-Med</name>
      <labeller>Unifirst First Aid Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>47682-406</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-12-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Medique Diotame</name>
      <labeller>Unifirst First Aid</labeller>
      <ndc-id/>
      <ndc-product-code>47682-220</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2008-12-30</started-marketing-on>
      <ended-marketing-on>2017-07-22</ended-marketing-on>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Medique Diotame</name>
      <labeller>Unifirst First Aid Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>47682-210</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-04-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Medique Diotame</name>
      <labeller>Unique First Aid Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>47682-165</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-04-05</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Meijer Stomach Relief</name>
      <labeller>Meijer Distribution Inc</labeller>
      <ndc-id/>
      <ndc-product-code>41250-324</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-03-07</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Meijer Stomach Relief</name>
      <labeller>Meijer Distribution Inc</labeller>
      <ndc-id/>
      <ndc-product-code>41250-878</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-03-14</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Meijer Stomach Relief Regular Strength</name>
      <labeller>Meijer Distribution Inc</labeller>
      <ndc-id/>
      <ndc-product-code>41250-671</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-03-07</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Meijer Stomach Relief Regular Strength</name>
      <labeller>Meijer Distribution Inc</labeller>
      <ndc-id/>
      <ndc-product-code>41250-670</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-03-07</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Meijer Stomach Relief Regular Strength</name>
      <labeller>Meijer Distribution Inc</labeller>
      <ndc-id/>
      <ndc-product-code>41250-211</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-03-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Moore Medical Bismuth</name>
      <labeller>Moore Medical</labeller>
      <ndc-id/>
      <ndc-product-code>55670-473</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2008-12-30</started-marketing-on>
      <ended-marketing-on>2017-07-22</ended-marketing-on>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Moore Medical Bismuth</name>
      <labeller>Moore Medical LLC</labeller>
      <ndc-id/>
      <ndc-product-code>55670-474</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-04-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Original Formula Stomach Relief</name>
      <labeller>Publix Supermarkets, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>56062-302</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-03-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pep Tum</name>
      <labeller>First Aid Direct</labeller>
      <ndc-id/>
      <ndc-product-code>53117-046</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-12-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepbis Regular</name>
      <labeller>Kc Pharmaceuticals, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>55651-264</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2004-03-04</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>17.5 mg/1mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepsis Relief</name>
      <labeller>Viva Pharmaceutical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02438666</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Peptic Relief</name>
      <labeller>Rebel Distributors</labeller>
      <ndc-id/>
      <ndc-product-code>21695-639</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-12-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief</name>
      <labeller>Super Valu (Equaline)</labeller>
      <ndc-id/>
      <ndc-product-code>41163-302</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-03-20</started-marketing-on>
      <ended-marketing-on>2017-03-31</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief</name>
      <labeller>Kroger</labeller>
      <ndc-id/>
      <ndc-product-code>30142-016</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-02-23</started-marketing-on>
      <ended-marketing-on>2017-06-01</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief</name>
      <labeller>Valu Merchandisers Company (Best Choice)</labeller>
      <ndc-id/>
      <ndc-product-code>63941-216</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-01-16</started-marketing-on>
      <ended-marketing-on>2017-03-31</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief</name>
      <labeller>Valu Merchandisers Company (Best Choice)</labeller>
      <ndc-id/>
      <ndc-product-code>63941-016</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-02-03</started-marketing-on>
      <ended-marketing-on>2017-03-31</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief</name>
      <labeller>Select Brand Dist.</labeller>
      <ndc-id/>
      <ndc-product-code>15127-550</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-11-03</started-marketing-on>
      <ended-marketing-on>2017-05-01</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief</name>
      <labeller>Rite Aid</labeller>
      <ndc-id/>
      <ndc-product-code>11822-0210</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-09-23</started-marketing-on>
      <ended-marketing-on>2017-05-31</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief</name>
      <labeller>Kinray</labeller>
      <ndc-id/>
      <ndc-product-code>63777-016</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-06-03</started-marketing-on>
      <ended-marketing-on>2017-06-01</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief</name>
      <labeller>H.E.B.</labeller>
      <ndc-id/>
      <ndc-product-code>59640-016</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-02-09</started-marketing-on>
      <ended-marketing-on>2017-06-01</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief</name>
      <labeller>Walgreens</labeller>
      <ndc-id/>
      <ndc-product-code>0363-0011</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-07-02</started-marketing-on>
      <ended-marketing-on>2015-06-30</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief</name>
      <labeller>Kroger</labeller>
      <ndc-id/>
      <ndc-product-code>30142-216</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-06-03</started-marketing-on>
      <ended-marketing-on>2017-06-01</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief</name>
      <labeller>Cardinal Health (Leader) 37205</labeller>
      <ndc-id/>
      <ndc-product-code>37205-302</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-04-02</started-marketing-on>
      <ended-marketing-on>2017-06-01</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief</name>
      <labeller>Amerisource Bergen Drug Corporation (Good Neighbor Pharmacy) 24385</labeller>
      <ndc-id/>
      <ndc-product-code>24385-016</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-09-18</started-marketing-on>
      <ended-marketing-on>2017-03-31</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief</name>
      <labeller>Chain Drug Consortium, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>68016-016</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-08-13</started-marketing-on>
      <ended-marketing-on>2019-12-31</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief</name>
      <labeller>P &amp; L Development, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>49580-0110</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-01-08</started-marketing-on>
      <ended-marketing-on>2019-12-31</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief</name>
      <labeller>L&amp;R Distributors, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>15127-319</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1998-07-16</started-marketing-on>
      <ended-marketing-on>2021-08-03</ended-marketing-on>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief</name>
      <labeller>RUGBY LABORATORIES</labeller>
      <ndc-id/>
      <ndc-product-code>0536-1021</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-02-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief</name>
      <labeller>Rite Aid Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>11822-0110</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-10-16</started-marketing-on>
      <ended-marketing-on>2019-12-30</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief</name>
      <labeller>Marc Glassman, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>68998-372</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-02-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief</name>
      <labeller>Marc Glassman, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>68998-526</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-04-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief</name>
      <labeller>Marc Glassman, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>68998-527</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-04-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief Cherry</name>
      <labeller>Kroger</labeller>
      <ndc-id/>
      <ndc-product-code>30142-136</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-06-03</started-marketing-on>
      <ended-marketing-on>2017-06-01</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief Cherry</name>
      <labeller>Valu Merchandisers Company (Best Choice)</labeller>
      <ndc-id/>
      <ndc-product-code>63941-136</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-01-08</started-marketing-on>
      <ended-marketing-on>2017-03-31</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief Cherry</name>
      <labeller>Select Brand Dist.</labeller>
      <ndc-id/>
      <ndc-product-code>15127-551</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-11-03</started-marketing-on>
      <ended-marketing-on>2017-05-01</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief Cherry</name>
      <labeller>Walgreens</labeller>
      <ndc-id/>
      <ndc-product-code>0363-0311</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-07-30</started-marketing-on>
      <ended-marketing-on>2017-05-30</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief Cherry</name>
      <labeller>Family Dollar (FAMILY WELLNESS)</labeller>
      <ndc-id/>
      <ndc-product-code>55319-311</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-07-29</started-marketing-on>
      <ended-marketing-on>2017-03-31</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief Cherry</name>
      <labeller>Chain Drug Consortium, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>68016-136</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-02-19</started-marketing-on>
      <ended-marketing-on>2019-12-31</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief Cherry</name>
      <labeller>Dolgencorp, Inc. (Dollar General &amp; Rexall)</labeller>
      <ndc-id/>
      <ndc-product-code>55910-136</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-01-07</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief Maximum Strength</name>
      <labeller>Chain Drug Consortium</labeller>
      <ndc-id/>
      <ndc-product-code>68016-024</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-07-08</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief Maximum Strength</name>
      <labeller>P &amp; L Development, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>49580-0210</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-07-29</started-marketing-on>
      <ended-marketing-on>2015-03-10</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief Maximum Strength</name>
      <labeller>P &amp; L Development, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>49580-3210</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-08-06</started-marketing-on>
      <ended-marketing-on>2015-03-10</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief Maximum Strength</name>
      <labeller>Super Valu (Equaline)</labeller>
      <ndc-id/>
      <ndc-product-code>41163-337</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-04-02</started-marketing-on>
      <ended-marketing-on>2017-03-31</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief Maximum Strength</name>
      <labeller>Kroger</labeller>
      <ndc-id/>
      <ndc-product-code>30142-024</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-02-23</started-marketing-on>
      <ended-marketing-on>2017-06-01</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief Maximum Strength</name>
      <labeller>Select Brand Dist.</labeller>
      <ndc-id/>
      <ndc-product-code>15127-555</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-11-03</started-marketing-on>
      <ended-marketing-on>2017-05-01</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief Maximum Strength</name>
      <labeller>H.E.B.</labeller>
      <ndc-id/>
      <ndc-product-code>59640-024</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-02-09</started-marketing-on>
      <ended-marketing-on>2017-06-01</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief Maximum Strength</name>
      <labeller>Kroger</labeller>
      <ndc-id/>
      <ndc-product-code>30142-224</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-06-03</started-marketing-on>
      <ended-marketing-on>2017-06-01</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief Maximum Strength</name>
      <labeller>Dolgencorp, Inc. (Dollar General &amp; Rexall)</labeller>
      <ndc-id/>
      <ndc-product-code>55910-024</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-08-06</started-marketing-on>
      <ended-marketing-on>2017-03-31</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief Maximum Strength</name>
      <labeller>Cardinal Health (Leader) 37205</labeller>
      <ndc-id/>
      <ndc-product-code>37205-337</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-04-02</started-marketing-on>
      <ended-marketing-on>2017-06-01</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief Maximum Strength</name>
      <labeller>P &amp; L Development, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>49580-0024</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-12-11</started-marketing-on>
      <ended-marketing-on>2019-12-31</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief Maximum Strength</name>
      <labeller>AmerisourceBergen Drug Corporation (Good Neighbor Pharmacy) 24385</labeller>
      <ndc-id/>
      <ndc-product-code>24385-337</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-01-01</started-marketing-on>
      <ended-marketing-on>2019-12-31</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief Maximum Strength</name>
      <labeller>Marc Glassman, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>68998-371</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-03-31</started-marketing-on>
      <ended-marketing-on>2021-12-30</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Peptic Relief original strength</name>
      <labeller>Physicians Total Care, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>54868-2898</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2008-12-11</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto Bismol</name>
      <labeller>Navajo Manufacturing Company Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>67751-155</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2016-09-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto Bismol</name>
      <labeller>Jc World Bell Wholesale Co., Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>50269-476</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2016-06-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto Bismol Caplet - 262mg/caplet</name>
      <labeller>Procter And Gamble</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02177994</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Pepto Bismol Diarrhea Liquicaps</name>
      <labeller>The Procter &amp; Gamble Manufacturing Company</labeller>
      <ndc-id/>
      <ndc-product-code>37000-537</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, liquid filled</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto Bismol Liquicaps</name>
      <labeller>The Procter &amp; Gamble Manufacturing Company</labeller>
      <ndc-id/>
      <ndc-product-code>37000-535</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, liquid filled</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto Diarrhea</name>
      <labeller>The Procter &amp; Gamble Manufacturing Company</labeller>
      <ndc-id/>
      <ndc-product-code>37000-538</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto Relief</name>
      <labeller>Advance Pharmaceutical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>17714-045</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2002-01-09</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto Relief</name>
      <labeller>Richmond Pharmaceuticals, Inc</labeller>
      <ndc-id/>
      <ndc-product-code>54738-102</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-06-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto-Bismol</name>
      <labeller>A S Medication Solutions</labeller>
      <ndc-id/>
      <ndc-product-code>54569-3285</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1989-03-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto-Bismol</name>
      <labeller>A-S Medication Solutions</labeller>
      <ndc-id/>
      <ndc-product-code>54569-4236</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2004-06-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto-Bismol</name>
      <labeller>Procter And Gamble</labeller>
      <ndc-id/>
      <ndc-product-code>37000-032</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1989-03-31</started-marketing-on>
      <ended-marketing-on>2019-10-10</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto-Bismol</name>
      <labeller>Procter And Gamble</labeller>
      <ndc-id/>
      <ndc-product-code>37000-475</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2004-06-30</started-marketing-on>
      <ended-marketing-on>2019-09-26</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto-Bismol</name>
      <labeller>Procter &amp; Gamble Manufactura S De Rl De Cv</labeller>
      <ndc-id/>
      <ndc-product-code>58933-477</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2004-06-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto-Bismol</name>
      <labeller>Procter And Gamble</labeller>
      <ndc-id/>
      <ndc-product-code>37000-476</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2004-06-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto-Bismol</name>
      <labeller>Procter &amp; Gamble Manufactura S De Rl De Cv</labeller>
      <ndc-id/>
      <ndc-product-code>58933-476</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2004-06-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto-Bismol</name>
      <labeller>Procter &amp; Gamble Manufactura S De Rl De Cv</labeller>
      <ndc-id/>
      <ndc-product-code>58933-018</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2004-06-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>525 mg/21</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto-Bismol</name>
      <labeller>Procter And Gamble</labeller>
      <ndc-id/>
      <ndc-product-code>37000-477</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2004-06-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto-Bismol</name>
      <labeller>Procter And Gamble</labeller>
      <ndc-id/>
      <ndc-product-code>37000-018</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2004-06-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>525 mg/21</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto-Bismol</name>
      <labeller>Lil' Drug Store Products, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>66715-9723</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-09-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto-Bismol</name>
      <labeller>Jc World Bell Wholesale Co., Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>50269-691</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-06-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto-Bismol</name>
      <labeller>A-S Medication Solutions</labeller>
      <ndc-id/>
      <ndc-product-code>50090-0553</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2004-06-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto-Bismol</name>
      <labeller>Savings Distributors LLC</labeller>
      <ndc-id/>
      <ndc-product-code>73097-010</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-07-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto-Bismol</name>
      <labeller>The Procter &amp; Gamble Manufacturing Company</labeller>
      <ndc-id/>
      <ndc-product-code>37000-402</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-09-12</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto-Bismol</name>
      <labeller>The Procter &amp; Gamble Manufacturing Company</labeller>
      <ndc-id/>
      <ndc-product-code>37000-402</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-09-12</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto-Bismol</name>
      <labeller>The Procter &amp; Gamble Manufacturing Company</labeller>
      <ndc-id/>
      <ndc-product-code>37000-438</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto-Bismol</name>
      <labeller>The Procter &amp; Gamble Manufacturing Company</labeller>
      <ndc-id/>
      <ndc-product-code>37000-403</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-03-05</started-marketing-on>
      <ended-marketing-on>2021-12-01</ended-marketing-on>
      <dosage-form/>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto-Bismol</name>
      <labeller>The Procter &amp; Gamble Manufacturing Company</labeller>
      <ndc-id/>
      <ndc-product-code>37000-403</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-03-05</started-marketing-on>
      <ended-marketing-on>2021-12-01</ended-marketing-on>
      <dosage-form/>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto-Bismol</name>
      <labeller>Procter And Gamble</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02097079</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>17.6 mg</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Pepto-Bismol and Pepto-Bismol To Go</name>
      <labeller>Procter And Gamble</labeller>
      <ndc-id/>
      <ndc-product-code>37000-017</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-09-17</started-marketing-on>
      <ended-marketing-on>2018-10-31</ended-marketing-on>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto-Bismol and Pepto-Bismol To Go</name>
      <labeller>Procter And Gamble</labeller>
      <ndc-id/>
      <ndc-product-code>37000-017</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-09-17</started-marketing-on>
      <ended-marketing-on>2018-10-31</ended-marketing-on>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto-Bismol Cherry</name>
      <labeller>Procter And Gamble</labeller>
      <ndc-id/>
      <ndc-product-code>37000-439</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto-bismol Chewables</name>
      <labeller>Procter And Gamble</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02237315</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2000-02-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Pepto-Bismol Diarrhea</name>
      <labeller>Procter &amp; Gamble Manufacturing México, S. de R.L. de C.V.</labeller>
      <ndc-id/>
      <ndc-product-code>58933-391</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>525 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto-Bismol Diarrhea</name>
      <labeller>The Procter &amp; Gamble Manufacturing Company</labeller>
      <ndc-id/>
      <ndc-product-code>37000-391</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>525 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto-bismol Extra</name>
      <labeller>Procter And Gamble</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02229668</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2000-02-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Pepto-Bismol InstaCool</name>
      <labeller>The Procter &amp; Gamble Manufacturing Company</labeller>
      <ndc-id/>
      <ndc-product-code>37000-691</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-07-09</started-marketing-on>
      <ended-marketing-on>2021-12-01</ended-marketing-on>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto-Bismol InstaCool</name>
      <labeller>Procter &amp; Gamble Manufactura S De Rl De Cv</labeller>
      <ndc-id/>
      <ndc-product-code>58933-691</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-07-09</started-marketing-on>
      <ended-marketing-on>2021-12-01</ended-marketing-on>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto-Bismol Max Strength</name>
      <labeller>Procter And Gamble</labeller>
      <ndc-id/>
      <ndc-product-code>37000-019</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1989-03-31</started-marketing-on>
      <ended-marketing-on>2019-10-10</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto-Bismol Max Strength</name>
      <labeller>Procter And Gamble</labeller>
      <ndc-id/>
      <ndc-product-code>37000-653</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2004-06-30</started-marketing-on>
      <ended-marketing-on>2019-09-13</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto-bismol Tab</name>
      <labeller>Richardson Vicks, Division Of The Procter &amp; Gamble Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00879037</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1991-12-31</started-marketing-on>
      <ended-marketing-on>1996-09-16</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Pepto-bismol Tablets</name>
      <labeller>Procter And Gamble</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02025906</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2000-02-18</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Pepto-Bismol To Go</name>
      <labeller>Procter And Gamble</labeller>
      <ndc-id/>
      <ndc-product-code>37000-016</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto-Bismol To Go</name>
      <labeller>Procter &amp; Gamble Manufactura S De Rl De Cv</labeller>
      <ndc-id/>
      <ndc-product-code>58933-016</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto-Bismol Ultra</name>
      <labeller>Procter And Gamble</labeller>
      <ndc-id/>
      <ndc-product-code>37000-440</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto-Bismol ULTRA</name>
      <labeller>Procter And Gamble</labeller>
      <ndc-id/>
      <ndc-product-code>37000-478</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-02-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>525 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto-Bismol ULTRA</name>
      <labeller>Procter &amp; Gamble Manufactura, S. De R.L. De C.V.</labeller>
      <ndc-id/>
      <ndc-product-code>58933-478</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-02-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>525 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto-Bismol Ultra Cherry</name>
      <labeller>Procter And Gamble</labeller>
      <ndc-id/>
      <ndc-product-code>37000-441</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pepto-bismol With Instacool</name>
      <labeller>Procter And Gamble</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02325896</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-01-21</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Percy Medicine</name>
      <labeller>Merrick Medicine Company, Inc</labeller>
      <ndc-id/>
      <ndc-product-code>0322-2222</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-09-09</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>1050 mg/10mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Personnel Sous-salicylate Bismuth 17.6mg/ml</name>
      <labeller>Therapex Division De E Z Em Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00876674</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1991-12-31</started-marketing-on>
      <ended-marketing-on>2007-09-04</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Pink Bismuth</name>
      <labeller>Pharmaceutical Associates, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0121-4803</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-09-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pink Bismuth</name>
      <labeller>Kareway Product, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>67510-0505</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-08-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pink Bismuth</name>
      <labeller>Qualitest</labeller>
      <ndc-id/>
      <ndc-product-code>0603-0235</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2003-04-28</started-marketing-on>
      <ended-marketing-on>2018-10-24</ended-marketing-on>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pink Bismuth</name>
      <labeller>We Care Distributor Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>70005-047</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2016-10-25</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pink Bismuth</name>
      <labeller>Gericare Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>57896-392</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2000-01-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pink Bismuth</name>
      <labeller>Preferreed Pharmaceuticals Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>68788-0190</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-12-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pink Bismuth</name>
      <labeller>Preferred Pharmaceuticals, Inc</labeller>
      <ndc-id/>
      <ndc-product-code>68788-235</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-12-01</started-marketing-on>
      <ended-marketing-on>2010-12-01</ended-marketing-on>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pink Bismuth</name>
      <labeller>RUGBY LABORATORIES</labeller>
      <ndc-id/>
      <ndc-product-code>0536-1810</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-04-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pink Bismuth Maximum Strength</name>
      <labeller>Rij Pharmaceutical Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>53807-192</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1999-03-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pink Bismuth Plus Antacid Relief Tablets</name>
      <labeller>Perrigo International</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02219204</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on>2000-10-10</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Pink Bismuth Regular Strength</name>
      <labeller>Aafes/Your Military Exchanges</labeller>
      <ndc-id/>
      <ndc-product-code>55301-372</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-08-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pink Bismuth Rose Liq 17.6mg/ml</name>
      <labeller>Technilab Pharma Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01946064</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1992-12-31</started-marketing-on>
      <ended-marketing-on>2000-09-07</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Pink Bismuth Subsalicylate Liq 17.6mg/ml</name>
      <labeller>Patheon Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00844365</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1992-12-31</started-marketing-on>
      <ended-marketing-on>2000-06-21</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Pink Bismuth-liq 17.6mg/ml</name>
      <labeller>Perrigo International</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02143534</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>1998-08-12</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Pink-Bismuth</name>
      <labeller>Guardian Drug Company</labeller>
      <ndc-id/>
      <ndc-product-code>53041-527</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2008-05-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pleasant Relief Liq 1.7%</name>
      <labeller>Golden Pride/Rawleigh</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02048469</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>1997-02-20</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Premier Value</name>
      <labeller>CHAIN DRUG CONSORTIUM,LLC</labeller>
      <ndc-id/>
      <ndc-product-code>68016-124</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-05-22</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Premier Value Diarrhea Relief Vanilla Flavor</name>
      <labeller>Pharmacy Value Alliance, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>68016-317</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-04-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>QC Anti Diarrheal Vanilla Regular Flavor</name>
      <labeller>QUALITY CHOICE (Chain Drug Marketing Association)</labeller>
      <ndc-id/>
      <ndc-product-code>63868-339</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-04-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>QC Pink Bismuth</name>
      <labeller>QUALITY CHOICE (Chain Drug Marketing Association)</labeller>
      <ndc-id/>
      <ndc-product-code>63868-171</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-04-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, film coated</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>QC Quality Choice Pink Bismuth Stomach Relief</name>
      <labeller>Chain Drug Manufacturing Assn</labeller>
      <ndc-id/>
      <ndc-product-code>63868-303</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-03-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>QC Stomach Relief Cherry Flavor</name>
      <labeller>QUALITY CHOICE (Chain Drug Marketing Association)</labeller>
      <ndc-id/>
      <ndc-product-code>63868-305</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-04-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>QC Stomach Relief Regular Strength</name>
      <labeller>QUALITY CHOICE (Chain Drug Marketing Association)</labeller>
      <ndc-id/>
      <ndc-product-code>63868-304</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-04-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Regular Strength Bismuth</name>
      <labeller>Juno Otc Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02468646</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-07-17</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Regular Strength Bismuth</name>
      <labeller>TEVA Canada Limited</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02418614</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-08-13</started-marketing-on>
      <ended-marketing-on>2019-07-09</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Regular Strength Pink Bismuth</name>
      <labeller>Raritan Pharmaceuticals Inc</labeller>
      <ndc-id/>
      <ndc-product-code>68163-706</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-05-13</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Regular Strength Pink Bismuth</name>
      <labeller>CVS Pharmacy, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>69842-766</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-09-25</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Rexall Bismuth</name>
      <labeller>Dolgencorp</labeller>
      <ndc-id/>
      <ndc-product-code>55910-469</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-09-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Rexall Bismuth</name>
      <labeller>Dolgencorp</labeller>
      <ndc-id/>
      <ndc-product-code>55910-337</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-09-06</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Rolaids Upset Stomach Relief</name>
      <labeller>Pfizer Canada Inc., Consumer Healthcare Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02289830</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Rx Act Stomach Relief</name>
      <labeller>H.E.B.</labeller>
      <ndc-id/>
      <ndc-product-code>37808-469</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1994-11-08</started-marketing-on>
      <ended-marketing-on>2012-06-01</ended-marketing-on>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ShopRite Stomach Relief</name>
      <labeller>Wakfern Food Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>41190-469</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2016-11-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ShopRite Stomach Relief</name>
      <labeller>Wakfern Food Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>41190-337</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-08-14</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ShopRite Stomach Relief</name>
      <labeller>Wakefern Food Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>41190-302</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-08-06</started-marketing-on>
      <ended-marketing-on>2019-11-30</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Signature care Upset Stomach Relief</name>
      <labeller>Safeway</labeller>
      <ndc-id/>
      <ndc-product-code>21130-132</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-10-24</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Soothe</name>
      <labeller>Walgreen Company</labeller>
      <ndc-id/>
      <ndc-product-code>0363-0346</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-05-06</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Soothe</name>
      <labeller>Walgreens</labeller>
      <ndc-id/>
      <ndc-product-code>0363-0073</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-01-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Soothe</name>
      <labeller>Walgreens</labeller>
      <ndc-id/>
      <ndc-product-code>0363-0025</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-01-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Soothe</name>
      <labeller>Walgreen Company</labeller>
      <ndc-id/>
      <ndc-product-code>0363-0319</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1998-07-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Soothe Maximum Strength</name>
      <labeller>Walgreens</labeller>
      <ndc-id/>
      <ndc-product-code>0363-0371</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-04-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Sound Body Stomach Relief</name>
      <labeller>Big Lots Stores, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>50594-007</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-05-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Sound Body Stomach Relief</name>
      <labeller>Big Lots Stores, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>50594-001</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-04-21</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Lil Drug Store Products</name>
      <labeller>Lil' Drug Store Products, Inc</labeller>
      <ndc-id/>
      <ndc-product-code>66715-6855</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-12-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief</name>
      <labeller>Sda Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>66424-045</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-09-27</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief</name>
      <labeller>Winco Foods</labeller>
      <ndc-id/>
      <ndc-product-code>67091-233</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-12-12</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief</name>
      <labeller>Chain Drug Consortium</labeller>
      <ndc-id/>
      <ndc-product-code>68016-392</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-09-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief</name>
      <labeller>CVS Health</labeller>
      <ndc-id/>
      <ndc-product-code>69842-394</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-11-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief</name>
      <labeller>Pura Cap Pharmaceutical Llc.</labeller>
      <ndc-id/>
      <ndc-product-code>51013-321</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-11-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief</name>
      <labeller>Hannaford Brothers Company</labeller>
      <ndc-id/>
      <ndc-product-code>41268-469</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1999-12-03</started-marketing-on>
      <ended-marketing-on>2012-06-01</ended-marketing-on>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief</name>
      <labeller>Hyvee</labeller>
      <ndc-id/>
      <ndc-product-code>42507-469</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1991-08-06</started-marketing-on>
      <ended-marketing-on>2012-06-01</ended-marketing-on>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief</name>
      <labeller>CVS Health</labeller>
      <ndc-id/>
      <ndc-product-code>69842-527</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2008-09-08</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>262 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach relief</name>
      <labeller>CVS Health</labeller>
      <ndc-id/>
      <ndc-product-code>69842-172</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-08-08</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief</name>
      <labeller>CVS Health</labeller>
      <ndc-id/>
      <ndc-product-code>59779-699</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1992-06-24</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief</name>
      <labeller>Rite Aid</labeller>
      <ndc-id/>
      <ndc-product-code>11822-0337</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-07-11</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief</name>
      <labeller>Shopko Stores Operating</labeller>
      <ndc-id/>
      <ndc-product-code>37012-302</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-11-14</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief</name>
      <labeller>Shopko Stores Operating</labeller>
      <ndc-id/>
      <ndc-product-code>37012-337</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-09-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief</name>
      <labeller>Kroger</labeller>
      <ndc-id/>
      <ndc-product-code>30142-337</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1990-09-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief</name>
      <labeller>Shopko Stores Operating</labeller>
      <ndc-id/>
      <ndc-product-code>37012-469</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-01-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief</name>
      <labeller>Meijer Distribution Inc</labeller>
      <ndc-id/>
      <ndc-product-code>41250-469</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-09-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief</name>
      <labeller>TOP CARE (Topco Associates LLC)</labeller>
      <ndc-id/>
      <ndc-product-code>36800-136</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-11-08</started-marketing-on>
      <ended-marketing-on>2018-12-31</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief</name>
      <labeller>Consumer Value Products, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>57243-557</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-10-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief</name>
      <labeller>Better Living Brands, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>21130-346</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-05-06</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief</name>
      <labeller>McKesson (Health Mart)</labeller>
      <ndc-id/>
      <ndc-product-code>62011-0393</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief</name>
      <labeller>Best Choice (Valu Merchandisers Company)</labeller>
      <ndc-id/>
      <ndc-product-code>63941-425</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-08-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief</name>
      <labeller>ARMY AND AIR FORCE EXCHANGE SERVICE</labeller>
      <ndc-id/>
      <ndc-product-code>55301-319</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1998-07-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief</name>
      <labeller>Harmon Store Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>63940-319</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1998-07-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief</name>
      <labeller>Rite Aid Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>11822-0319</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1998-07-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief</name>
      <labeller>SUPERVALU INC.</labeller>
      <ndc-id/>
      <ndc-product-code>41163-346</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-05-06</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief</name>
      <labeller>Your Military Exchange</labeller>
      <ndc-id/>
      <ndc-product-code>55301-124</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-03-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief</name>
      <labeller>Spirit Pharmaceuticals LLC</labeller>
      <ndc-id/>
      <ndc-product-code>68210-0469</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-06-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, liquid filled</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief</name>
      <labeller>H E B</labeller>
      <ndc-id/>
      <ndc-product-code>37808-346</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-05-06</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief</name>
      <labeller>WAL-MART STORES INC</labeller>
      <ndc-id/>
      <ndc-product-code>49035-346</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-07-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach relief</name>
      <labeller>Strategic Sourcing Services LLC</labeller>
      <ndc-id/>
      <ndc-product-code>49348-511</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-09-27</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief</name>
      <labeller>Family Dollar (FAMILY WELLNESS)</labeller>
      <ndc-id/>
      <ndc-product-code>55319-736</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-10-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief</name>
      <labeller>Aurohealth LLC</labeller>
      <ndc-id/>
      <ndc-product-code>58602-516</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-09-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief</name>
      <labeller>Harris Teeter</labeller>
      <ndc-id/>
      <ndc-product-code>72036-006</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-04-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief</name>
      <labeller>Aurohealth LLC</labeller>
      <ndc-id/>
      <ndc-product-code>58602-302</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-04-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief</name>
      <labeller>Rite Aid Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>11822-0346</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-05-06</started-marketing-on>
      <ended-marketing-on>2021-09-10</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief</name>
      <labeller>WinCo Foods, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>67091-235</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-12-12</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief</name>
      <labeller>Strategic Sourcing Services LLC</labeller>
      <ndc-id/>
      <ndc-product-code>62011-0126</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-01-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief - Maximum Strength</name>
      <labeller>AptaPharma Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>76281-538</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-10-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief - Regular Strength</name>
      <labeller>AptaPharma Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>76281-537</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-10-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Cherry</name>
      <labeller>Care One (American Sales Company)</labeller>
      <ndc-id/>
      <ndc-product-code>41520-136</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-11-19</started-marketing-on>
      <ended-marketing-on>2017-03-31</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Cherry</name>
      <labeller>Freds Inc</labeller>
      <ndc-id/>
      <ndc-product-code>55315-070</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-03-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Cherry</name>
      <labeller>Family Dollar (FAMILY WELLNESS)</labeller>
      <ndc-id/>
      <ndc-product-code>55319-425</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-03-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Chewable Flavoured Tablets</name>
      <labeller>Guardian Drug Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02392151</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Stomach Relief Chewable Tablets</name>
      <labeller>Guardian Drug Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02389215</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-11-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Stomach relief chewables</name>
      <labeller>Kroger</labeller>
      <ndc-id/>
      <ndc-product-code>30142-469</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1991-10-10</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>stomach relief Maximum Strength</name>
      <labeller>Western Family Foods</labeller>
      <ndc-id/>
      <ndc-product-code>55312-337</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1991-06-15</started-marketing-on>
      <ended-marketing-on>2012-08-12</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>stomach relief Maximum Strength</name>
      <labeller>Hannaford Brothers Company</labeller>
      <ndc-id/>
      <ndc-product-code>41268-337</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-06-29</started-marketing-on>
      <ended-marketing-on>2012-12-29</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>stomach relief Maximum Strength</name>
      <labeller>Hyvee</labeller>
      <ndc-id/>
      <ndc-product-code>42507-337</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1989-07-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Maximum Strength</name>
      <labeller>McKesson (Sunmark)</labeller>
      <ndc-id/>
      <ndc-product-code>49348-923</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-11-08</started-marketing-on>
      <ended-marketing-on>2019-12-31</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Maximum Strength</name>
      <labeller>Western Family Foods, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>55312-071</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-03-31</started-marketing-on>
      <ended-marketing-on>2019-12-31</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Maximum Strength</name>
      <labeller>Demoulas Super Markets Inc</labeller>
      <ndc-id/>
      <ndc-product-code>53942-558</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-10-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Maximum Strength</name>
      <labeller>Safeway, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>21130-371</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-06-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Maximum Strength</name>
      <labeller>Best Choice (Valu Merchandisers Company)</labeller>
      <ndc-id/>
      <ndc-product-code>63941-371</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-03-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Maximum Strength</name>
      <labeller>Freds Inc</labeller>
      <ndc-id/>
      <ndc-product-code>55315-371</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-03-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Maximum Strength</name>
      <labeller>Select Brand Dist.</labeller>
      <ndc-id/>
      <ndc-product-code>15127-671</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-09-30</started-marketing-on>
      <ended-marketing-on>2020-12-31</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Maximum Strength</name>
      <labeller>Publix Supermarkets, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>56062-071</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2016-07-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Maximum Strength</name>
      <labeller>Care One (American Sales Company)</labeller>
      <ndc-id/>
      <ndc-product-code>41520-682</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-09-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Maximum Strength</name>
      <labeller>Healthy Accents (DZA Brands, LLC)</labeller>
      <ndc-id/>
      <ndc-product-code>55316-371</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-02-28</started-marketing-on>
      <ended-marketing-on>2020-12-31</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Maximum Strength</name>
      <labeller>AmerisourceBergen (Good Neighbor Pharmacy) 46122</labeller>
      <ndc-id/>
      <ndc-product-code>46122-308</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-09-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Maximum Strength</name>
      <labeller>Aurohealth LLC</labeller>
      <ndc-id/>
      <ndc-product-code>58602-301</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-04-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Maximum Strength</name>
      <labeller>CVS Pharmacy, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>69842-005</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2016-01-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Maximum Strength</name>
      <labeller>Dolgencorp, Inc. (Dollar General &amp; Rexall)</labeller>
      <ndc-id/>
      <ndc-product-code>55910-482</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-07-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Maximum Strength</name>
      <labeller>EQUATE (Wal-Mart Stores, Inc.)</labeller>
      <ndc-id/>
      <ndc-product-code>49035-371</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-10-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Maximum Strength</name>
      <labeller>Strategic Sourcing Services LLC</labeller>
      <ndc-id/>
      <ndc-product-code>62011-0127</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-12-31</started-marketing-on>
      <ended-marketing-on>2021-12-30</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>STOMACH RELIEF Maximum Strength</name>
      <labeller>Pharmacy Value Alliance, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>68016-558</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-12-17</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Maximum Strength</name>
      <labeller>The Kroger Co.</labeller>
      <ndc-id/>
      <ndc-product-code>30142-371</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2016-03-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Maximum Strength</name>
      <labeller>Family Dollar (FAMILY WELLNESS)</labeller>
      <ndc-id/>
      <ndc-product-code>55319-371</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Maximum Strength ReadyInCase</name>
      <labeller>P &amp; L Development, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>49580-0371</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-12-31</started-marketing-on>
      <ended-marketing-on>2021-12-30</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Multi-Symptom</name>
      <labeller>Greenbrier International, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>33992-0319</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1998-07-16</started-marketing-on>
      <ended-marketing-on>2019-07-08</ended-marketing-on>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Original</name>
      <labeller>CVS Health</labeller>
      <ndc-id/>
      <ndc-product-code>59779-616</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1992-06-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Original Formula</name>
      <labeller>Publix Supermarkets, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>56062-372</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Original Strength</name>
      <labeller>Hannaford Brothers Company</labeller>
      <ndc-id/>
      <ndc-product-code>41268-302</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-06-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Original Strength</name>
      <labeller>Western Family Foods</labeller>
      <ndc-id/>
      <ndc-product-code>55312-302</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1989-03-15</started-marketing-on>
      <ended-marketing-on>2012-10-14</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Original Strength</name>
      <labeller>Kroger</labeller>
      <ndc-id/>
      <ndc-product-code>30142-302</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1989-01-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Original Strength</name>
      <labeller>HYVEE INC</labeller>
      <ndc-id/>
      <ndc-product-code>42507-302</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1989-02-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Original Strength</name>
      <labeller>AmerisourceBergen Drug Corporation (Good Neighbor Pharmacy) 24385</labeller>
      <ndc-id/>
      <ndc-product-code>24385-302</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-05-06</started-marketing-on>
      <ended-marketing-on>2019-12-31</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Original Strength</name>
      <labeller>AmerisourceBergen (Good Neighbor Pharmacy) 46122</labeller>
      <ndc-id/>
      <ndc-product-code>46122-306</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-07-31</started-marketing-on>
      <ended-marketing-on>2020-12-31</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Original Strength</name>
      <labeller>Family Dollar (FAMILY WELLNESS)</labeller>
      <ndc-id/>
      <ndc-product-code>55319-724</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-10-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Original Strength</name>
      <labeller>Family Dollar (FAMILY WELLNESS)</labeller>
      <ndc-id/>
      <ndc-product-code>55319-372</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Regular Strength</name>
      <labeller>Western Family Foods, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>55312-372</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-01-31</started-marketing-on>
      <ended-marketing-on>2019-12-31</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Regular Strength</name>
      <labeller>McKesson (Sunmark)</labeller>
      <ndc-id/>
      <ndc-product-code>70677-0062</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Regular Strength</name>
      <labeller>Demoulas Super Markets Inc</labeller>
      <ndc-id/>
      <ndc-product-code>53942-557</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-10-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Regular Strength</name>
      <labeller>Safeway, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>21130-372</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-06-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Regular Strength</name>
      <labeller>P &amp; L Development, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>49580-0425</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2016-05-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Regular Strength</name>
      <labeller>Best Choice (Valu Merchandisers Company)</labeller>
      <ndc-id/>
      <ndc-product-code>63941-372</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-03-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Regular Strength</name>
      <labeller>Freds Inc</labeller>
      <ndc-id/>
      <ndc-product-code>55315-372</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-03-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Regular Strength</name>
      <labeller>The Kroger Co.</labeller>
      <ndc-id/>
      <ndc-product-code>30142-372</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-10-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Regular Strength</name>
      <labeller>EQUATE (Wal-Mart Stores, Inc.)</labeller>
      <ndc-id/>
      <ndc-product-code>49035-372</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-11-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief regular strength</name>
      <labeller>Rite Aid Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>11822-0273</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-03-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Regular Strength</name>
      <labeller>TOP CARE (Topco Associates LLC)</labeller>
      <ndc-id/>
      <ndc-product-code>36800-625</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-03-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Regular Strength</name>
      <labeller>Dolgencorp, Inc. (Dollar General &amp; Rexall)</labeller>
      <ndc-id/>
      <ndc-product-code>55910-372</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-03-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Regular Strength</name>
      <labeller>Care One (Retail Business Services, LLC.)</labeller>
      <ndc-id/>
      <ndc-product-code>72476-425</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-06-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Regular Strength</name>
      <labeller>Select Brand Dist.</labeller>
      <ndc-id/>
      <ndc-product-code>15127-425</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-07-31</started-marketing-on>
      <ended-marketing-on>2020-12-31</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Regular Strength</name>
      <labeller>Strategic Sourcing Services LLC</labeller>
      <ndc-id/>
      <ndc-product-code>49348-922</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-01-31</started-marketing-on>
      <ended-marketing-on>2020-12-31</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Regular Strength</name>
      <labeller>ASSURED / DOLLAR TREE (Greenbrier International, Inc.)</labeller>
      <ndc-id/>
      <ndc-product-code>33992-0372</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2016-04-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Regular Strength</name>
      <labeller>TOP CARE (Topco Associates LLC)</labeller>
      <ndc-id/>
      <ndc-product-code>36800-045</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-02-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Regular Strength</name>
      <labeller>Select Brand Dist.</labeller>
      <ndc-id/>
      <ndc-product-code>15127-372</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-01-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Regular Strength</name>
      <labeller>Care One (American Sales Company)</labeller>
      <ndc-id/>
      <ndc-product-code>41520-425</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-01-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief regular strength</name>
      <labeller>Care One (American Sales Company)</labeller>
      <ndc-id/>
      <ndc-product-code>41520-372</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-09-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Regular Strength</name>
      <labeller>P &amp; L Development, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>49580-0624</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-09-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Regular Strength</name>
      <labeller>Healthy Accents (DZA Brands, LLC)</labeller>
      <ndc-id/>
      <ndc-product-code>55316-372</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-03-31</started-marketing-on>
      <ended-marketing-on>2020-12-31</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Regular Strength</name>
      <labeller>Dolgencorp, Inc. (Dollar General &amp; Rexall)</labeller>
      <ndc-id/>
      <ndc-product-code>55910-624</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-10-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Regular Strength</name>
      <labeller>P &amp; L Development, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>49580-0724</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-10-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Regular Strength</name>
      <labeller>Strategic Sourcing Services LLC</labeller>
      <ndc-id/>
      <ndc-product-code>62011-0435</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-10-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Regular Strength</name>
      <labeller>P &amp; L Development, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>49580-0872</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-06-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>STOMACH RELIEF Regular Strength</name>
      <labeller>Pharmacy Value Alliance, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>68016-557</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-12-17</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Regular Strength</name>
      <labeller>Hy-Vee</labeller>
      <ndc-id/>
      <ndc-product-code>42507-825</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-10-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Regular Strength</name>
      <labeller>Best Choice (Valu Merchandisers Company)</labeller>
      <ndc-id/>
      <ndc-product-code>63941-724</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-11-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Regular Strength ReadyInCase</name>
      <labeller>P &amp; L Development, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>49580-0372</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-09-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Ultra</name>
      <labeller>McKesson (Health Mart)</labeller>
      <ndc-id/>
      <ndc-product-code>62011-0394</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Ultra</name>
      <labeller>Family Dollar (FAMILY WELLNESS)</labeller>
      <ndc-id/>
      <ndc-product-code>55319-842</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-02-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Ultra</name>
      <labeller>AmerisourceBergen (Good Neighbor Pharmacy) 46122</labeller>
      <ndc-id/>
      <ndc-product-code>46122-595</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-03-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Ultra</name>
      <labeller>Safeway, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>21130-642</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-03-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Ultra</name>
      <labeller>EQUATE (Wal-Mart Stores, Inc.)</labeller>
      <ndc-id/>
      <ndc-product-code>49035-642</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-03-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Ultra</name>
      <labeller>Best Choice (Valu Merchandisers Company)</labeller>
      <ndc-id/>
      <ndc-product-code>63941-842</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-04-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Ultra</name>
      <labeller>Care One (Retail Business Services, LLC.)</labeller>
      <ndc-id/>
      <ndc-product-code>72476-642</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-06-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Ultra</name>
      <labeller>Publix Supermarkets, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>56062-842</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-07-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Ultra</name>
      <labeller>Family Dollar (FAMILY WELLNESS)</labeller>
      <ndc-id/>
      <ndc-product-code>55319-737</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-10-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Ultra</name>
      <labeller>Dolgencorp, Inc. (Dollar General &amp; Rexall)</labeller>
      <ndc-id/>
      <ndc-product-code>55910-844</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-09-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Ultra Strength</name>
      <labeller>P &amp; L Development, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>49580-0842</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-02-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Relief Ultra Strength</name>
      <labeller>P &amp; L Development, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>49580-0737</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-09-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomak-care Multi Action</name>
      <labeller>Novartis</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02262363</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2005-06-20</started-marketing-on>
      <ended-marketing-on>2014-07-23</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Sun Mark Stomach Relief</name>
      <labeller>Mc Kesson</labeller>
      <ndc-id/>
      <ndc-product-code>49348-177</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2003-08-21</started-marketing-on>
      <ended-marketing-on>2012-06-01</ended-marketing-on>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Sunmark Stomach Relief</name>
      <labeller>Mc Kesson</labeller>
      <ndc-id/>
      <ndc-product-code>49348-192</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2003-08-21</started-marketing-on>
      <ended-marketing-on>2011-11-10</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Sunmark stomach relief</name>
      <labeller>Strategic Sourcing Services LLC</labeller>
      <ndc-id/>
      <ndc-product-code>49348-014</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2016-02-12</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Sunmark Stomach relief</name>
      <labeller>Strategic Sourcing Services LLC</labeller>
      <ndc-id/>
      <ndc-product-code>49348-953</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-09-24</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>sunmark stomach relief Maximum Strength</name>
      <labeller>Mc Kesson</labeller>
      <ndc-id/>
      <ndc-product-code>49348-338</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2003-09-13</started-marketing-on>
      <ended-marketing-on>2012-02-13</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Threda</name>
      <labeller>Menper Distributors</labeller>
      <ndc-id/>
      <ndc-product-code>53145-057</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-02-21</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>262 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>TopCare Regular Strength</name>
      <labeller>Topco Associates LLC</labeller>
      <ndc-id/>
      <ndc-product-code>36800-661</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-05-07</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Topcare Stomach Relief</name>
      <labeller>Topco Associates</labeller>
      <ndc-id/>
      <ndc-product-code>36800-337</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1989-12-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Topcare Stomach Relief Original Strength</name>
      <labeller>Topco Associates</labeller>
      <ndc-id/>
      <ndc-product-code>36800-469</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1991-09-17</started-marketing-on>
      <ended-marketing-on>2012-06-01</ended-marketing-on>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Topcare stomach relief original strength</name>
      <labeller>Topco Associates</labeller>
      <ndc-id/>
      <ndc-product-code>36800-302</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1989-01-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>TopCare Stomach Relief Regular Strength</name>
      <labeller>Topco Associates LLC</labeller>
      <ndc-id/>
      <ndc-product-code>36800-338</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-03-07</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>TopCare Stomach Relief Ultra Strength</name>
      <labeller>Topco Associates LLC</labeller>
      <ndc-id/>
      <ndc-product-code>36800-341</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-03-14</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Ultra Bismuth</name>
      <labeller>Dolgencorp, Inc. (Dollar General &amp; Rexall)</labeller>
      <ndc-id/>
      <ndc-product-code>55910-843</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-09-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>525 mg/15mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Ultra Strenght Pink Bismuth</name>
      <labeller>TARGET Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>11673-907</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-03-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>1050 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Ultra Strength digestive relief</name>
      <labeller>The Kroger Co.</labeller>
      <ndc-id/>
      <ndc-product-code>30142-138</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-11-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>525 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Up and Up 5-symptom Digestive Relief</name>
      <labeller>TARGET Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>11673-122</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-03-12</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Up and Up 5-symptom Digestive Relief</name>
      <labeller>TARGET Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>11673-125</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-09-07</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Up and Up Digestive Relief</name>
      <labeller>Target Corporation.</labeller>
      <ndc-id/>
      <ndc-product-code>11673-005</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-03-10</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Up and Up Digestive Relief</name>
      <labeller>TARGET Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>11673-706</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-03-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Up and Up Stomach Relief</name>
      <labeller>Target Corporation.</labeller>
      <ndc-id/>
      <ndc-product-code>11673-302</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-02-13</started-marketing-on>
      <ended-marketing-on>2016-05-01</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>525 mg/30mL</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Upset Stomach Relief</name>
      <labeller>Safeway</labeller>
      <ndc-id/>
      <ndc-product-code>21130-469</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-08-08</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Upset Stomach Relief to Go</name>
      <labeller>Breakthrough Products Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>51596-004</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-09-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Powder</dosage-form>
      <strength>525 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Walgreen</name>
      <labeller>Walgreen Company</labeller>
      <ndc-id/>
      <ndc-product-code>0363-9124</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-03-05</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Walgreen</name>
      <labeller>WALGREEN CO.</labeller>
      <ndc-id/>
      <ndc-product-code>0363-9125</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-05-14</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, film coated</dosage-form>
      <strength>262 mg/1</strength>
      <route>Oral</route>
      <fda-application-number>part335</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Watkins Settelz</name>
      <labeller>Watkins Incorporated</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00373656</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1954-12-31</started-marketing-on>
      <ended-marketing-on>2011-08-04</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
  </products>
  <international-brands>
    <international-brand>
      <name>Maalox Multi-Action</name>
      <company/>
    </international-brand>
  </international-brands>
  <mixtures>
    <mixture>
      <name>Desempacho Cucharadas</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pink Bismuth</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pink Bismuth</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepbis Regular</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Chewable</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Original Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Original Formula Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Kola-Pectin DS</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pink Bismuth</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth subsalicylate</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief original strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Kaopectate Regular Strength Vanilla Flavor Anti Diarrheal</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Estomax</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-Bismol</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Threda</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pink-Bismuth</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismutina</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Green Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismatrol</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismatrol</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Kaopectate</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Upset Stomach Relief to Go</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Medique Diotame</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Moore Medical Bismuth</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Maximum strength Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth Subsalicylate</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Family Care Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-Bismol To Go</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth Tabs</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Healthy Accents Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pink Bismuth</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Multi-Symptom</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>GNP Pink Bismuth</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>GNP Pink Bismuth</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Rexall Bismuth</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>HELIDAC Therapy</name>
      <ingredients>Bismuth subsalicylate + Metronidazole + Tetracycline</ingredients>
    </mixture>
    <mixture>
      <name>ShopRite Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Good Sense Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Healthy Accents Stomach Relief Original Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-Bismol</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach relief chewables</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>ShopRite Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Flanadol Pronto Bismuth</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief Cherry</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismol</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>equate stomach relief Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Equate Stomach Relief Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pink Bismuth</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief Cherry</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Original Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>sunmark stomach relief Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>stomach relief Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Sun Mark Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief Cherry</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Healthy Accents Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Sunmark Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Rx Act Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Cherry</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Up and Up Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Careone Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>stomach relief Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pink Bismuth</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief Cherry</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Maximum strength Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Leader Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Leader Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Healthy Accents Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Topcare Stomach Relief Original Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief Cherry</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>7-Select Pepto Bismol</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>stomach relief Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Sound Body Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Leader stomach relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Leader Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Equaline Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Rexall Bismuth</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Topcare Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-Bismol</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-Bismol Cherry</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-Bismol Max Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-Bismol Max Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-Bismol</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Good Sense Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Good Sense Stomach Relief original strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Being Well stomach relief original strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-Bismol To Go</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Original Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Up and Up Digestive Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Equaline Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Original</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Careone Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-Bismol</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-Bismol</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-Bismol</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Dg Health Stomach Relief Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Topcare stomach relief original strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-Bismol</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-Bismol</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-Bismol Ultra</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-Bismol Ultra Cherry</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-Bismol ULTRA</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-Bismol ULTRA</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Sound Body Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pink Bismuth Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Kao-Bis</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Ka Pec</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-Bismol</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-Bismol and Pepto-Bismol To Go</name>
      <ingredients>Bismuth subsalicylate + Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-Bismol and Pepto-Bismol To Go</name>
      <ingredients>Bismuth subsalicylate + Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pink Bismuth</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Equate Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-Bismol</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Equaline Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Equaline Maximum Strength Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>HEB Stomach Relief Cherry</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>HEB Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>HEB Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Signature care Upset Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Gastrobiz</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-Bismol</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief Cherry</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Leader Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Leader Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pep Tum</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Geri-pectate Peppermint Flavor</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Geri-pectate Vanilla Flavor</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pink Bismuth</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Kao-tin Peppermint Flavor</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief - Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief - Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Ultra Strenght Pink Bismuth</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Up and Up Digestive Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Soothe</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Lil Drug Store Products</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Circle K Stomach</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Ultra</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Basic Care Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Anti-Diarrheal</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Soothe Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Soothe</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Ultra</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-Bismol</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Soothe</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief Cherry</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Meijer Stomach Relief Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Meijer Stomach Relief Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-Bismol Diarrhea</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-Bismol Diarrhea</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto Bismol Liquicaps</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Ultra Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth Subsalicylate</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto Bismol Diarrhea Liquicaps</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto Diarrhea</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Meijer Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Original Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Cherry</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Cherry</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Medique Diotame</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Medi-First Pep-T-Med</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Walgreen</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Moore Medical Bismuth</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth subsalicylate</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>QC Pink Bismuth</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>QC Anti Diarrheal Vanilla Regular Flavor</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>QC Stomach Relief Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>QC Stomach Relief Cherry Flavor</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Ultra</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Up and Up 5-symptom Digestive Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Ultra</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief regular strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Ultra</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>CVS Health Anti-Diarrheal Vanilla</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Meijer Stomach Relief Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Meijer Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>CVS Health Stomach relief Cherry Flavor</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Ultra</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>TopCare Stomach Relief Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>TopCare Stomach Relief Ultra Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Leader Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Leader Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>HEB Stomach Relief Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>HEB Stomach Relief Max Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Premier Value Diarrhea Relief Vanilla Flavor</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Premier Value</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>HEB Diarrhea Relief Vanilla Flavor</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismatrol</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>TopCare Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Regular Strength Pink Bismuth</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Walgreen</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Leader Maximum Strength Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Ultra</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-Bismol</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Ultra</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Sunmark stomach relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Kaopectate Regular Strength Vanilla Flavor Anti Diarrheal</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Original Formula</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Health Mart Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Health Mart Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-Bismol</name>
      <ingredients>Bismuth subsalicylate + Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-Bismol</name>
      <ingredients>Bismuth subsalicylate + Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>7 Select Pink Bismuth</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Percy Medicine</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Up and Up 5-symptom Digestive Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>QC Quality Choice Pink Bismuth Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Chewable Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth Chewable</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Leader Stomach Relief original strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Digestive Relief Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Sunmark Stomach relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismatrol</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pink Bismuth Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Health Mart Stomach relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Digestive Relief Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Regular Strength Pink Bismuth</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Ultra Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief regular strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Digestive Relief Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Digestive Relief Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Original Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Original Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Ultra</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Original Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismatrol</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismatrol</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>ShopRite Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth Subsalicylate/Metronidazole/Tetracycline Hydrochloride</name>
      <ingredients>Bismuth subsalicylate + Metronidazole + Tetracycline</ingredients>
    </mixture>
    <mixture>
      <name>Ultra Strength digestive relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth Subsalicylate Maximum Strength Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth Subsalicylate Maximum Strength Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Kaopectate Regular Strength Peppermint Flavor Anti Diarrheal</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Kaopectate Extra Strength Peppermint Flavor Anti Diarrheal</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Kaopectate Regular Strength Cherry Flavor</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Kaopectate Regular Strength Vanilla Flavor Anti Diarrheal</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Medique Diotame</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Maximum Strength Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Peptic Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Maximum Strength ReadyInCase</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Regular Strength ReadyInCase</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto Bismol</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Upset Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismatrol</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-Bismol</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Soothe</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Ultra</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Ultra Bismuth</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto Bismol</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-Bismol InstaCool</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-Bismol InstaCool</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-Bismol</name>
      <ingredients>Bismuth subsalicylate + Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-Bismol</name>
      <ingredients>Bismuth subsalicylate + Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>STOMACH RELIEF Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>STOMACH RELIEF Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismatrol</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismatrol</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth Subsalicylate</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Original Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Maximum Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Estomaquil Polvo</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Regular Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth Subsalicylate 262 mg</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-bismol Extra</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-bismol Chewables</name>
      <ingredients>Bismuth subsalicylate + Calcium carbonate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth + Antacid (chewable Tablets)</name>
      <ingredients>Bismuth subsalicylate + Calcium carbonate</ingredients>
    </mixture>
    <mixture>
      <name>Extra-strength Bismuth</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth Subsalicylate Liquid</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Chewable Bismuth Tablets With Calcium Carbonate</name>
      <ingredients>Bismuth subsalicylate + Calcium carbonate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-bismol With Instacool</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth Subsalicylate Caplets</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Chewable Tablets</name>
      <ingredients>Bismuth subsalicylate + Calcium carbonate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth Liq 17.6mg/ml</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Personnel Sous-salicylate Bismuth 17.6mg/ml</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismed Chewable Tablets</name>
      <ingredients>Bismuth subsalicylate + Calcium carbonate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth Subsalicylate Suspension 17.6mg/ml</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismed Liq 17.66mg/ml</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pink Bismuth Subsalicylate Liq 17.6mg/ml</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pink Bismuth-liq 17.6mg/ml</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pink Bismuth Plus Antacid Relief Tablets</name>
      <ingredients>Bismuth subsalicylate + Calcium carbonate</ingredients>
    </mixture>
    <mixture>
      <name>Watkins Settelz</name>
      <ingredients>Bismuth subsalicylate + Pectin + Phenyl salicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-bismol Tab</name>
      <ingredients>Bismuth subsalicylate + Calcium carbonate</ingredients>
    </mixture>
    <mixture>
      <name>Cherry Flavour Pepto-bismol Tab</name>
      <ingredients>Bismuth subsalicylate + Calcium carbonate</ingredients>
    </mixture>
    <mixture>
      <name>Pink Bismuth Rose Liq 17.6mg/ml</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pleasant Relief Liq 1.7%</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth Subsalicylate Suspension 17.6mg/ml</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-bismol Tablets</name>
      <ingredients>Bismuth subsalicylate + Calcium carbonate</ingredients>
    </mixture>
    <mixture>
      <name>Bismylate-bismuth Subsalicylate Sus 17.6gm/ml</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth Caplets</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth Chewable Tablets</name>
      <ingredients>Bismuth subsalicylate + Calcium carbonate</ingredients>
    </mixture>
    <mixture>
      <name>Stomak-care Multi Action</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth (original Formula)</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth (cherry Flavour)</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Mcneil Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth Liquid</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth Caplets</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth Tablets With Calcium Carbonate</name>
      <ingredients>Bismuth subsalicylate + Calcium carbonate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth Subsalicylate Liquid</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth Subsalicylate Liquid Extra Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Relief Chewable Flavoured Tablets</name>
      <ingredients>Bismuth subsalicylate + Calcium carbonate</ingredients>
    </mixture>
    <mixture>
      <name>Extra Strength Bismuth</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepsis Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto-Bismol</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Pepto Bismol Caplet - 262mg/caplet</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth Subsalicylate Liquid Extra Strength</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth Caplets</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth Liquid</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Rolaids Upset Stomach Relief</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth Subsalicylate</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Regular Strength Bismuth</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth Caplets</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth Chewables</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Extra Strength Bismuth</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Extra Strength Bismuth Subsalicylate Liquid</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth Caplets</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Bismuth Chewables</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Regular Strength Bismuth</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
    <mixture>
      <name>Extra Strength Bismuth</name>
      <ingredients>Bismuth subsalicylate</ingredients>
    </mixture>
  </mixtures>
  <packagers>
    <packager>
      <name>Amend</name>
      <url/>
    </packager>
    <packager>
      <name>Chattem Chemicals Inc.</name>
      <url>http://www.chattem.com</url>
    </packager>
    <packager>
      <name>Dispensing Solutions</name>
      <url>http://www.drxdispensing.com</url>
    </packager>
    <packager>
      <name>Kroger Co.</name>
      <url>http://www.kroger.com</url>
    </packager>
    <packager>
      <name>Major Pharmaceuticals</name>
      <url>http://www.majorpharmaceuticals.com</url>
    </packager>
    <packager>
      <name>Novartis AG</name>
      <url>http://www.novartis.com</url>
    </packager>
    <packager>
      <name>Pharma Pac LLC</name>
      <url>http://www.pharmapacllc.com</url>
    </packager>
    <packager>
      <name>Procter &amp; Gamble</name>
      <url>http://www.pg.com</url>
    </packager>
    <packager>
      <name>Publix Super Markets</name>
      <url>http://www.publix.com</url>
    </packager>
    <packager>
      <name>Walgreen Co.</name>
      <url>http://www.walgreens.com</url>
    </packager>
  </packagers>
  <manufacturers/>
  <prices>
    <price>
      <description>Maalox plus x-strength susp</description>
      <cost currency="USD">0.01</cost>
      <unit>ml</unit>
    </price>
    <price>
      <description>Maalox total relief (bismuth)</description>
      <cost currency="USD">0.01</cost>
      <unit>ml</unit>
    </price>
    <price>
      <description>Bismuth 262 mg/15ml susp</description>
      <cost currency="USD">0.02</cost>
      <unit>ml</unit>
    </price>
    <price>
      <description>Maalox max strength multi symp</description>
      <cost currency="USD">0.02</cost>
      <unit>ml</unit>
    </price>
    <price>
      <description>Maalox maximum strength susp</description>
      <cost currency="USD">0.02</cost>
      <unit>ml</unit>
    </price>
    <price>
      <description>Pepto-bismol max str susp</description>
      <cost currency="USD">0.02</cost>
      <unit>ml</unit>
    </price>
    <price>
      <description>Pub calcium carb 1000 mg tablet</description>
      <cost currency="USD">0.02</cost>
      <unit>tablet</unit>
    </price>
    <price>
      <description>Magnesium-aluminum suspension</description>
      <cost currency="USD">0.03</cost>
      <unit>ml</unit>
    </price>
    <price>
      <description>Maalox max quick dissolve tablet</description>
      <cost currency="USD">0.06</cost>
      <unit>tablet</unit>
    </price>
    <price>
      <description>Stomach relief tablet</description>
      <cost currency="USD">0.06</cost>
      <unit>tablet</unit>
    </price>
    <price>
      <description>Bismatrol 262 mg tablet</description>
      <cost currency="USD">0.09</cost>
      <unit>tablet</unit>
    </price>
    <price>
      <description>Maalox advanced tablet chew</description>
      <cost currency="USD">0.09</cost>
      <unit>tablet</unit>
    </price>
    <price>
      <description>Maalox quick dissolve tablet</description>
      <cost currency="USD">0.09</cost>
      <unit>tablet</unit>
    </price>
    <price>
      <description>Soothe caplets</description>
      <cost currency="USD">0.12</cost>
      <unit>caplet</unit>
    </price>
    <price>
      <description>Calcium carb 500 mg tablet chew</description>
      <cost currency="USD">0.14</cost>
      <unit>tablet</unit>
    </price>
    <price>
      <description>Pepto-bismol caplet</description>
      <cost currency="USD">0.14</cost>
      <unit>caplet</unit>
    </price>
    <price>
      <description>Bismuth subsalicylate powdr</description>
      <cost currency="USD">0.17</cost>
      <unit>g</unit>
    </price>
    <price>
      <description>Jr maalox plus antigas tablet chew</description>
      <cost currency="USD">0.17</cost>
      <unit>tablet</unit>
    </price>
    <price>
      <description>Gas-x with maalox chew tablet</description>
      <cost currency="USD">0.25</cost>
      <unit>tablet</unit>
    </price>
    <price>
      <description>Kaopectate 262 mg caplet</description>
      <cost currency="USD">0.37</cost>
      <unit>caplet</unit>
    </price>
  </prices>
  <categories>
    <category>
      <category>Acids, Carbocyclic</category>
      <mesh-id>D000146</mesh-id>
    </category>
    <category>
      <category>Antacids and Adsorbents</category>
      <mesh-id/>
    </category>
    <category>
      <category>Antidiarrheals</category>
      <mesh-id>D000930</mesh-id>
    </category>
    <category>
      <category>Benzene Derivatives</category>
      <mesh-id>D001555</mesh-id>
    </category>
    <category>
      <category>Benzoates</category>
      <mesh-id>D001565</mesh-id>
    </category>
    <category>
      <category>Bismuth containing drugs</category>
      <mesh-id/>
    </category>
    <category>
      <category>Elements</category>
      <mesh-id>D004602</mesh-id>
    </category>
    <category>
      <category>Elements, Radioactive</category>
      <mesh-id>D004603</mesh-id>
    </category>
    <category>
      <category>Gastrointestinal Agents</category>
      <mesh-id>D005765</mesh-id>
    </category>
    <category>
      <category>Helicobacter Infections</category>
      <mesh-id>D016481</mesh-id>
    </category>
    <category>
      <category>Hydroxy Acids</category>
      <mesh-id>D006880</mesh-id>
    </category>
    <category>
      <category>Hydroxybenzoates</category>
      <mesh-id>D062385</mesh-id>
    </category>
    <category>
      <category>Isotopes</category>
      <mesh-id>D007554</mesh-id>
    </category>
    <category>
      <category>Metals</category>
      <mesh-id>D008670</mesh-id>
    </category>
    <category>
      <category>Metals, Heavy</category>
      <mesh-id>D019216</mesh-id>
    </category>
    <category>
      <category>Neurotoxic agents</category>
      <mesh-id/>
    </category>
    <category>
      <category>Phenols</category>
      <mesh-id>D010636</mesh-id>
    </category>
    <category>
      <category>Radioisotopes</category>
      <mesh-id>D011868</mesh-id>
    </category>
    <category>
      <category>Salicylates</category>
      <mesh-id>D012459</mesh-id>
    </category>
  </categories>
  <affected-organisms/>
  <dosages>
    <dosage>
      <form>Tablet</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Tablet</form>
      <route>Oral</route>
      <strength>262 mg/434mg</strength>
    </dosage>
    <dosage>
      <form>Suspension</form>
      <route>Oral</route>
      <strength>17.5 mg</strength>
    </dosage>
    <dosage>
      <form>Suspension</form>
      <route>Oral</route>
      <strength>17.6 mg</strength>
    </dosage>
    <dosage>
      <form>Tablet</form>
      <route>Oral</route>
      <strength>262 mg</strength>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Tablet, film coated</form>
      <route>Oral</route>
      <strength>262 mg/1</strength>
    </dosage>
    <dosage>
      <form>Tablet</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Tablet, chewable</form>
      <route>Oral</route>
      <strength>262 mg/1</strength>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Oral</route>
      <strength>262 mg/15mL</strength>
    </dosage>
    <dosage>
      <form>Powder</form>
      <route>Oral</route>
      <strength>262 mg/1</strength>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Oral</route>
      <strength>1050 mg/30mL</strength>
    </dosage>
    <dosage>
      <form>Suspension</form>
      <route>Oral</route>
      <strength>1050 mg/30mL</strength>
    </dosage>
    <dosage>
      <form>Suspension</form>
      <route>Oral</route>
      <strength>525 mg/30mL</strength>
    </dosage>
    <dosage>
      <form>Kit</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Oral</route>
      <strength>35.0 mg/1mL</strength>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Oral</route>
      <strength>17.47 mg/1mL</strength>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Oral</route>
      <strength>525 mg/15mL</strength>
    </dosage>
    <dosage>
      <form>Suspension</form>
      <route>Oral</route>
      <strength>17.5 mg/1mL</strength>
    </dosage>
    <dosage>
      <form>Tablet</form>
      <route>Oral</route>
      <strength>262 mg/1</strength>
    </dosage>
    <dosage>
      <form>Suspension</form>
      <route>Oral</route>
      <strength>525 mg/15mL</strength>
    </dosage>
    <dosage>
      <form>Capsule, liquid filled</form>
      <route>Oral</route>
      <strength>262 mg/1</strength>
    </dosage>
    <dosage>
      <form/>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Oral</route>
      <strength>525 mg/30mL</strength>
    </dosage>
    <dosage>
      <form>Tablet</form>
      <route>Oral</route>
      <strength>525 mg/21</strength>
    </dosage>
    <dosage>
      <form>Tablet, chewable</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Suspension</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Tablet</form>
      <route>Oral</route>
      <strength>525 mg/1</strength>
    </dosage>
    <dosage>
      <form>Tablet, chewable</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Oral</route>
      <strength>1050 mg/10mL</strength>
    </dosage>
    <dosage>
      <form>Suspension</form>
      <route>Oral</route>
      <strength>262 mg/15mL</strength>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Oral</route>
      <strength>262 mg/30mL</strength>
    </dosage>
    <dosage>
      <form>Powder</form>
      <route>Oral</route>
      <strength>525 mg/1</strength>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Oral</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes/>
  <ahfs-codes>
    <ahfs-code>56:04.00</ahfs-code>
    <ahfs-code>56:08.00</ahfs-code>
  </ahfs-codes>
  <pdb-entries/>
  <msds>//s3-us-west-2.amazonaws.com/drugbank/msds/DB01294.pdf?1265922751</msds>
  <patents/>
  <food-interactions/>
  <drug-interactions>
    <drug-interaction>
      <drugbank-id>DB06767</drugbank-id>
      <name>Ammonium chloride</name>
      <description>The serum concentration of Bismuth subsalicylate can be increased when it is combined with Ammonium chloride.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01381</drugbank-id>
      <name>Ginkgo biloba</name>
      <description>Ginkgo biloba may increase the anticoagulant activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00070</drugbank-id>
      <name>Hyaluronidase (ovine)</name>
      <description>The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00563</drugbank-id>
      <name>Methotrexate</name>
      <description>The serum concentration of Methotrexate can be increased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06813</drugbank-id>
      <name>Pralatrexate</name>
      <description>The serum concentration of Pralatrexate can be increased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01032</drugbank-id>
      <name>Probenecid</name>
      <description>The therapeutic efficacy of Probenecid can be decreased when used in combination with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00374</drugbank-id>
      <name>Treprostinil</name>
      <description>The risk or severity of bleeding can be increased when Treprostinil is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00254</drugbank-id>
      <name>Doxycycline</name>
      <description>The serum concentration of Doxycycline can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00256</drugbank-id>
      <name>Lymecycline</name>
      <description>The serum concentration of Lymecycline can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00453</drugbank-id>
      <name>Clomocycline</name>
      <description>The serum concentration of Clomocycline can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00595</drugbank-id>
      <name>Oxytetracycline</name>
      <description>The serum concentration of Oxytetracycline can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00618</drugbank-id>
      <name>Demeclocycline</name>
      <description>The serum concentration of Demeclocycline can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00759</drugbank-id>
      <name>Tetracycline</name>
      <description>The serum concentration of Tetracycline can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00931</drugbank-id>
      <name>Metacycline</name>
      <description>The serum concentration of Metacycline can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01017</drugbank-id>
      <name>Minocycline</name>
      <description>The serum concentration of Minocycline can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12035</drugbank-id>
      <name>Sarecycline</name>
      <description>The serum concentration of Sarecycline can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12455</drugbank-id>
      <name>Omadacycline</name>
      <description>The serum concentration of Omadacycline can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13092</drugbank-id>
      <name>Meclocycline</name>
      <description>The serum concentration of Meclocycline can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13264</drugbank-id>
      <name>Penimepicycline</name>
      <description>The serum concentration of Penimepicycline can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01009</drugbank-id>
      <name>Ketoprofen</name>
      <description>The risk or severity of bleeding and gastrointestinal bleeding can be increased when Bismuth subsalicylate is combined with Ketoprofen.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09214</drugbank-id>
      <name>Dexketoprofen</name>
      <description>The risk or severity of bleeding and gastrointestinal bleeding can be increased when Bismuth subsalicylate is combined with Dexketoprofen.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00266</drugbank-id>
      <name>Dicoumarol</name>
      <description>Bismuth subsalicylate may increase the anticoagulant activities of Dicoumarol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00498</drugbank-id>
      <name>Phenindione</name>
      <description>Bismuth subsalicylate may increase the anticoagulant activities of Phenindione.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00682</drugbank-id>
      <name>Warfarin</name>
      <description>Bismuth subsalicylate may increase the anticoagulant activities of Warfarin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00946</drugbank-id>
      <name>Phenprocoumon</name>
      <description>Bismuth subsalicylate may increase the anticoagulant activities of Phenprocoumon.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01418</drugbank-id>
      <name>Acenocoumarol</name>
      <description>Bismuth subsalicylate may increase the anticoagulant activities of Acenocoumarol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB03410</drugbank-id>
      <name>4-hydroxycoumarin</name>
      <description>Bismuth subsalicylate may increase the anticoagulant activities of 4-hydroxycoumarin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04665</drugbank-id>
      <name>Coumarin</name>
      <description>Bismuth subsalicylate may increase the anticoagulant activities of Coumarin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08496</drugbank-id>
      <name>(R)-warfarin</name>
      <description>Bismuth subsalicylate may increase the anticoagulant activities of (R)-warfarin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08794</drugbank-id>
      <name>Ethyl biscoumacetate</name>
      <description>Bismuth subsalicylate may increase the anticoagulant activities of Ethyl biscoumacetate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13136</drugbank-id>
      <name>Fluindione</name>
      <description>Bismuth subsalicylate may increase the anticoagulant activities of Fluindione.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13275</drugbank-id>
      <name>Clorindione</name>
      <description>Bismuth subsalicylate may increase the anticoagulant activities of Clorindione.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13347</drugbank-id>
      <name>Diphenadione</name>
      <description>Bismuth subsalicylate may increase the anticoagulant activities of Diphenadione.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13451</drugbank-id>
      <name>Tioclomarol</name>
      <description>Bismuth subsalicylate may increase the anticoagulant activities of Tioclomarol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14055</drugbank-id>
      <name>(S)-Warfarin</name>
      <description>Bismuth subsalicylate may increase the anticoagulant activities of (S)-Warfarin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00390</drugbank-id>
      <name>Digoxin</name>
      <description>The serum concentration of Digoxin can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00511</drugbank-id>
      <name>Acetyldigitoxin</name>
      <description>The serum concentration of Acetyldigitoxin can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01078</drugbank-id>
      <name>Deslanoside</name>
      <description>The serum concentration of Deslanoside can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01092</drugbank-id>
      <name>Ouabain</name>
      <description>The serum concentration of Ouabain can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01396</drugbank-id>
      <name>Digitoxin</name>
      <description>The serum concentration of Digitoxin can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12843</drugbank-id>
      <name>Oleandrin</name>
      <description>The serum concentration of Oleandrin can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13240</drugbank-id>
      <name>Cymarin</name>
      <description>The serum concentration of Cymarin can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13307</drugbank-id>
      <name>Proscillaridin</name>
      <description>The serum concentration of Proscillaridin can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13401</drugbank-id>
      <name>Metildigoxin</name>
      <description>The serum concentration of Metildigoxin can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13467</drugbank-id>
      <name>Lanatoside C</name>
      <description>The serum concentration of Lanatoside C can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13537</drugbank-id>
      <name>Gitoformate</name>
      <description>The serum concentration of Gitoformate can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13691</drugbank-id>
      <name>Acetyldigoxin</name>
      <description>The serum concentration of Acetyldigoxin can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13756</drugbank-id>
      <name>Peruvoside</name>
      <description>The serum concentration of Peruvoside can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00352</drugbank-id>
      <name>Tioguanine</name>
      <description>The metabolism of Tioguanine can be decreased when combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00993</drugbank-id>
      <name>Azathioprine</name>
      <description>The metabolism of Azathioprine can be decreased when combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01033</drugbank-id>
      <name>Mercaptopurine</name>
      <description>The metabolism of Mercaptopurine can be decreased when combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09275</drugbank-id>
      <name>Bismuth subcitrate potassium</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Bismuth subcitrate potassium.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11281</drugbank-id>
      <name>Bismuth subcarbonate</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Bismuth subcarbonate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13209</drugbank-id>
      <name>Bismuth subnitrate</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Bismuth subnitrate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13909</drugbank-id>
      <name>Bismuth subgallate</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Bismuth subgallate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13910</drugbank-id>
      <name>Valproate bismuth</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Valproate bismuth.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00001</drugbank-id>
      <name>Lepirudin</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Lepirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00006</drugbank-id>
      <name>Bivalirudin</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Bivalirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00009</drugbank-id>
      <name>Alteplase</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Alteplase.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00013</drugbank-id>
      <name>Urokinase</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Urokinase.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00015</drugbank-id>
      <name>Reteplase</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Reteplase.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00029</drugbank-id>
      <name>Anistreplase</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Anistreplase.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00031</drugbank-id>
      <name>Tenecteplase</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Tenecteplase.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00054</drugbank-id>
      <name>Abciximab</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Abciximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00055</drugbank-id>
      <name>Drotrecogin alfa</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Drotrecogin alfa.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00086</drugbank-id>
      <name>Streptokinase</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Streptokinase.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00261</drugbank-id>
      <name>Anagrelide</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Anagrelide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00278</drugbank-id>
      <name>Argatroban</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Argatroban.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00407</drugbank-id>
      <name>Ardeparin</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Ardeparin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00569</drugbank-id>
      <name>Fondaparinux</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Fondaparinux.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00686</drugbank-id>
      <name>Pentosan polysulfate</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Pentosan polysulfate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00975</drugbank-id>
      <name>Dipyridamole</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Dipyridamole.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01088</drugbank-id>
      <name>Iloprost</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Iloprost.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01109</drugbank-id>
      <name>Heparin</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Heparin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01225</drugbank-id>
      <name>Enoxaparin</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Enoxaparin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01240</drugbank-id>
      <name>Epoprostenol</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Epoprostenol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04898</drugbank-id>
      <name>Ximelagatran</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Ximelagatran.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04925</drugbank-id>
      <name>Desmoteplase</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Desmoteplase.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04932</drugbank-id>
      <name>Defibrotide</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Defibrotide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05099</drugbank-id>
      <name>Ancrod</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Ancrod.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05229</drugbank-id>
      <name>Beraprost</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Beraprost.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05254</drugbank-id>
      <name>Fibrinolysin</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Fibrinolysin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06209</drugbank-id>
      <name>Prasugrel</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Prasugrel.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06228</drugbank-id>
      <name>Rivaroxaban</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Rivaroxaban.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06271</drugbank-id>
      <name>Sulodexide</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Sulodexide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06294</drugbank-id>
      <name>Semuloparin</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Semuloparin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06406</drugbank-id>
      <name>Idraparinux</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Idraparinux.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06441</drugbank-id>
      <name>Cangrelor</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Cangrelor.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06543</drugbank-id>
      <name>Astaxanthin</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Astaxanthin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06605</drugbank-id>
      <name>Apixaban</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Apixaban.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06635</drugbank-id>
      <name>Otamixaban</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Otamixaban.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06679</drugbank-id>
      <name>Amediplase</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Amediplase.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06695</drugbank-id>
      <name>Dabigatran etexilate</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Dabigatran etexilate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06754</drugbank-id>
      <name>Danaparoid</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Danaparoid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06779</drugbank-id>
      <name>Dalteparin</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Dalteparin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06822</drugbank-id>
      <name>Tinzaparin</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Tinzaparin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB07767</drugbank-id>
      <name>Ferulic acid</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Ferulic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08813</drugbank-id>
      <name>Nadroparin</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Nadroparin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08814</drugbank-id>
      <name>Triflusal</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Triflusal.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08816</drugbank-id>
      <name>Ticagrelor</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Ticagrelor.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08994</drugbank-id>
      <name>Ditazole</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Ditazole.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09030</drugbank-id>
      <name>Vorapaxar</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Vorapaxar.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09075</drugbank-id>
      <name>Edoxaban</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Edoxaban.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09125</drugbank-id>
      <name>Potassium citrate</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Potassium citrate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09154</drugbank-id>
      <name>Sodium citrate</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Sodium citrate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09255</drugbank-id>
      <name>Dextran</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Dextran.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09258</drugbank-id>
      <name>Bemiparin</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Bemiparin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09259</drugbank-id>
      <name>Reviparin</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Reviparin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09260</drugbank-id>
      <name>Parnaparin</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Parnaparin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09261</drugbank-id>
      <name>Certoparin</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Certoparin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11095</drugbank-id>
      <name>Desirudin</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Desirudin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11154</drugbank-id>
      <name>Zinc citrate</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Zinc citrate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11166</drugbank-id>
      <name>Antithrombin Alfa</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Antithrombin Alfa.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11312</drugbank-id>
      <name>Protein C</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Protein C.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11598</drugbank-id>
      <name>Antithrombin III human</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Antithrombin III human.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11984</drugbank-id>
      <name>Letaxaban</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Letaxaban.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12289</drugbank-id>
      <name>Darexaban</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Darexaban.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12364</drugbank-id>
      <name>Betrixaban</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Betrixaban.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12598</drugbank-id>
      <name>Nafamostat</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Nafamostat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12726</drugbank-id>
      <name>Monteplase</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Monteplase.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12831</drugbank-id>
      <name>Gabexate</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Gabexate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13149</drugbank-id>
      <name>Protein S human</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Protein S human.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13199</drugbank-id>
      <name>Brinase</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Brinase.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13616</drugbank-id>
      <name>Melagatran</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Melagatran.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13646</drugbank-id>
      <name>Saruplase</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Saruplase.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14094</drugbank-id>
      <name>Tocopherylquinone</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Tocopherylquinone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14598</drugbank-id>
      <name>Edetate calcium disodium anhydrous</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Edetate calcium disodium anhydrous.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14600</drugbank-id>
      <name>Edetate disodium anhydrous</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Edetate disodium anhydrous.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14726</drugbank-id>
      <name>Dabigatran</name>
      <description>The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Dabigatran.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00178</drugbank-id>
      <name>Ramipril</name>
      <description>The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Ramipril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00492</drugbank-id>
      <name>Fosinopril</name>
      <description>The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Fosinopril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00519</drugbank-id>
      <name>Trandolapril</name>
      <description>The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Trandolapril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00542</drugbank-id>
      <name>Benazepril</name>
      <description>The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Benazepril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00584</drugbank-id>
      <name>Enalapril</name>
      <description>The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Enalapril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00691</drugbank-id>
      <name>Moexipril</name>
      <description>The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Moexipril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00722</drugbank-id>
      <name>Lisinopril</name>
      <description>The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Lisinopril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00790</drugbank-id>
      <name>Perindopril</name>
      <description>The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Perindopril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00881</drugbank-id>
      <name>Quinapril</name>
      <description>The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Quinapril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00886</drugbank-id>
      <name>Omapatrilat</name>
      <description>The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Omapatrilat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01180</drugbank-id>
      <name>Rescinnamine</name>
      <description>The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Rescinnamine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01197</drugbank-id>
      <name>Captopril</name>
      <description>The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Captopril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01340</drugbank-id>
      <name>Cilazapril</name>
      <description>The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Cilazapril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01348</drugbank-id>
      <name>Spirapril</name>
      <description>The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Spirapril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08836</drugbank-id>
      <name>Temocapril</name>
      <description>The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Temocapril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09477</drugbank-id>
      <name>Enalaprilat</name>
      <description>The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Enalaprilat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11783</drugbank-id>
      <name>Imidapril</name>
      <description>The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Imidapril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13166</drugbank-id>
      <name>Zofenopril</name>
      <description>The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Zofenopril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13312</drugbank-id>
      <name>Delapril</name>
      <description>The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Delapril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14125</drugbank-id>
      <name>Benazeprilat</name>
      <description>The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Benazeprilat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14207</drugbank-id>
      <name>Fosinoprilat</name>
      <description>The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Fosinoprilat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14208</drugbank-id>
      <name>Ramiprilat</name>
      <description>The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Ramiprilat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14209</drugbank-id>
      <name>Trandolaprilat</name>
      <description>The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Trandolaprilat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14210</drugbank-id>
      <name>Moexiprilat</name>
      <description>The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Moexiprilat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14213</drugbank-id>
      <name>Perindoprilat</name>
      <description>The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Perindoprilat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14217</drugbank-id>
      <name>Quinaprilat</name>
      <description>The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Quinaprilat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14231</drugbank-id>
      <name>Quinoline Yellow WS</name>
      <description>The risk or severity of renal failure can be increased when Bismuth subsalicylate is combined with Quinoline Yellow WS.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00214</drugbank-id>
      <name>Torasemide</name>
      <description>The risk or severity of adverse effects can be increased when Bismuth subsalicylate is combined with Torasemide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00887</drugbank-id>
      <name>Bumetanide</name>
      <description>The risk or severity of adverse effects can be increased when Bismuth subsalicylate is combined with Bumetanide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00903</drugbank-id>
      <name>Etacrynic acid</name>
      <description>The risk or severity of adverse effects can be increased when Bismuth subsalicylate is combined with Etacrynic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02925</drugbank-id>
      <name>Piretanide</name>
      <description>The risk or severity of adverse effects can be increased when Bismuth subsalicylate is combined with Piretanide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08961</drugbank-id>
      <name>Azosemide</name>
      <description>The risk or severity of adverse effects can be increased when Bismuth subsalicylate is combined with Azosemide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00311</drugbank-id>
      <name>Ethoxzolamide</name>
      <description>The risk or severity of adverse effects can be increased when Bismuth subsalicylate is combined with Ethoxzolamide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00703</drugbank-id>
      <name>Methazolamide</name>
      <description>The risk or severity of adverse effects can be increased when Bismuth subsalicylate is combined with Methazolamide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00819</drugbank-id>
      <name>Acetazolamide</name>
      <description>The risk or severity of adverse effects can be increased when Bismuth subsalicylate is combined with Acetazolamide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00909</drugbank-id>
      <name>Zonisamide</name>
      <description>The risk or severity of adverse effects can be increased when Bismuth subsalicylate is combined with Zonisamide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01144</drugbank-id>
      <name>Diclofenamide</name>
      <description>The risk or severity of adverse effects can be increased when Bismuth subsalicylate is combined with Diclofenamide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06370</drugbank-id>
      <name>Indisulam</name>
      <description>The risk or severity of adverse effects can be increased when Bismuth subsalicylate is combined with Indisulam.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00233</drugbank-id>
      <name>Aminosalicylic acid</name>
      <description>The risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when Aminosalicylic acid is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00936</drugbank-id>
      <name>Salicylic acid</name>
      <description>The risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when Salicylic acid is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01250</drugbank-id>
      <name>Olsalazine</name>
      <description>The risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when Olsalazine is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06251</drugbank-id>
      <name>Dersalazine</name>
      <description>The risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when Bismuth subsalicylate is combined with Dersalazine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06807</drugbank-id>
      <name>Phenyl aminosalicylate</name>
      <description>The risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when Bismuth subsalicylate is combined with Phenyl aminosalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09543</drugbank-id>
      <name>Methyl salicylate</name>
      <description>The risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when Bismuth subsalicylate is combined with Methyl salicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13509</drugbank-id>
      <name>Aloxiprin</name>
      <description>The risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when Bismuth subsalicylate is combined with Aloxiprin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13538</drugbank-id>
      <name>Guacetisal</name>
      <description>The risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when Bismuth subsalicylate is combined with Guacetisal.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13612</drugbank-id>
      <name>Carbaspirin calcium</name>
      <description>The risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when Bismuth subsalicylate is combined with Carbaspirin calcium.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14006</drugbank-id>
      <name>Choline salicylate</name>
      <description>The risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when Bismuth subsalicylate is combined with Choline salicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14026</drugbank-id>
      <name>Thiosalicylic acid</name>
      <description>The risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when Bismuth subsalicylate is combined with Thiosalicylic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00313</drugbank-id>
      <name>Valproic acid</name>
      <description>The serum concentration of Valproic acid can be increased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00159</drugbank-id>
      <name>Icosapent</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Icosapent.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00244</drugbank-id>
      <name>Mesalazine</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Mesalazine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00328</drugbank-id>
      <name>Indomethacin</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Indomethacin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00461</drugbank-id>
      <name>Nabumetone</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Nabumetone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00465</drugbank-id>
      <name>Ketorolac</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Ketorolac.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00469</drugbank-id>
      <name>Tenoxicam</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Tenoxicam.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00500</drugbank-id>
      <name>Tolmetin</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Tolmetin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00554</drugbank-id>
      <name>Piroxicam</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Piroxicam.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00573</drugbank-id>
      <name>Fenoprofen</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Fenoprofen.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00586</drugbank-id>
      <name>Diclofenac</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Diclofenac.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00605</drugbank-id>
      <name>Sulindac</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Sulindac.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00712</drugbank-id>
      <name>Flurbiprofen</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Flurbiprofen.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00749</drugbank-id>
      <name>Etodolac</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Etodolac.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00784</drugbank-id>
      <name>Mefenamic acid</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Mefenamic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00788</drugbank-id>
      <name>Naproxen</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Naproxen.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00795</drugbank-id>
      <name>Sulfasalazine</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Sulfasalazine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00812</drugbank-id>
      <name>Phenylbutazone</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Phenylbutazone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00814</drugbank-id>
      <name>Meloxicam</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Meloxicam.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00821</drugbank-id>
      <name>Carprofen</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Carprofen.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00861</drugbank-id>
      <name>Diflunisal</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Diflunisal.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00870</drugbank-id>
      <name>Suprofen</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Suprofen.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00939</drugbank-id>
      <name>Meclofenamic acid</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Meclofenamic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00945</drugbank-id>
      <name>Acetylsalicylic acid</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Acetylsalicylic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00963</drugbank-id>
      <name>Bromfenac</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Bromfenac.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00991</drugbank-id>
      <name>Oxaprozin</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Oxaprozin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01014</drugbank-id>
      <name>Balsalazide</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Balsalazide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01397</drugbank-id>
      <name>Magnesium salicylate</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Magnesium salicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01399</drugbank-id>
      <name>Salsalate</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Salsalate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01401</drugbank-id>
      <name>Choline magnesium trisalicylate</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Choline magnesium trisalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01419</drugbank-id>
      <name>Antrafenine</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Antrafenine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01435</drugbank-id>
      <name>Antipyrine</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Antipyrine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01600</drugbank-id>
      <name>Tiaprofenic acid</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Tiaprofenic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06725</drugbank-id>
      <name>Lornoxicam</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Lornoxicam.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06736</drugbank-id>
      <name>Aceclofenac</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Aceclofenac.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06802</drugbank-id>
      <name>Nepafenac</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Nepafenac.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09213</drugbank-id>
      <name>Dexibuprofen</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Dexibuprofen.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09215</drugbank-id>
      <name>Droxicam</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Droxicam.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11079</drugbank-id>
      <name>Trolamine salicylate</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Trolamine salicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13346</drugbank-id>
      <name>Bufexamac</name>
      <description>The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Bufexamac.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00343</drugbank-id>
      <name>Diltiazem</name>
      <description>The risk or severity of bleeding can be increased when Diltiazem is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00661</drugbank-id>
      <name>Verapamil</name>
      <description>The risk or severity of bleeding can be increased when Verapamil is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00180</drugbank-id>
      <name>Flunisolide</name>
      <description>The serum concentration of Flunisolide can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00443</drugbank-id>
      <name>Betamethasone</name>
      <description>The serum concentration of Betamethasone can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00620</drugbank-id>
      <name>Triamcinolone</name>
      <description>The serum concentration of Triamcinolone can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00635</drugbank-id>
      <name>Prednisone</name>
      <description>The serum concentration of Prednisone can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00687</drugbank-id>
      <name>Fludrocortisone</name>
      <description>The serum concentration of Fludrocortisone can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00741</drugbank-id>
      <name>Hydrocortisone</name>
      <description>The serum concentration of Hydrocortisone can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00860</drugbank-id>
      <name>Prednisolone</name>
      <description>The serum concentration of Prednisolone can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00959</drugbank-id>
      <name>Methylprednisolone</name>
      <description>The serum concentration of Methylprednisolone can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01108</drugbank-id>
      <name>Trilostane</name>
      <description>The serum concentration of Trilostane can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01222</drugbank-id>
      <name>Budesonide</name>
      <description>The serum concentration of Budesonide can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01234</drugbank-id>
      <name>Dexamethasone</name>
      <description>The serum concentration of Dexamethasone can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01285</drugbank-id>
      <name>Corticotropin</name>
      <description>The serum concentration of Corticotropin can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01380</drugbank-id>
      <name>Cortisone acetate</name>
      <description>The serum concentration of Cortisone acetate can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01384</drugbank-id>
      <name>Paramethasone</name>
      <description>The serum concentration of Paramethasone can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04630</drugbank-id>
      <name>Aldosterone</name>
      <description>The serum concentration of Aldosterone can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09378</drugbank-id>
      <name>Fluprednisolone</name>
      <description>The serum concentration of Fluprednisolone can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09383</drugbank-id>
      <name>Meprednisone</name>
      <description>The serum concentration of Meprednisone can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11529</drugbank-id>
      <name>Melengestrol</name>
      <description>The serum concentration of Melengestrol can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11921</drugbank-id>
      <name>Deflazacort</name>
      <description>The serum concentration of Deflazacort can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13003</drugbank-id>
      <name>Cortivazol</name>
      <description>The serum concentration of Cortivazol can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13208</drugbank-id>
      <name>Prednylidene</name>
      <description>The serum concentration of Prednylidene can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13843</drugbank-id>
      <name>Cloprednol</name>
      <description>The serum concentration of Cloprednol can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14681</drugbank-id>
      <name>Cortisone</name>
      <description>The serum concentration of Cortisone can be decreased when it is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00063</drugbank-id>
      <name>Eptifibatide</name>
      <description>The risk or severity of bleeding can be increased when Eptifibatide is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00208</drugbank-id>
      <name>Ticlopidine</name>
      <description>The risk or severity of bleeding can be increased when Ticlopidine is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00758</drugbank-id>
      <name>Clopidogrel</name>
      <description>The risk or severity of bleeding can be increased when Clopidogrel is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00775</drugbank-id>
      <name>Tirofiban</name>
      <description>The risk or severity of bleeding can be increased when Tirofiban is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00806</drugbank-id>
      <name>Pentoxifylline</name>
      <description>The risk or severity of bleeding can be increased when Pentoxifylline is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01138</drugbank-id>
      <name>Sulfinpyrazone</name>
      <description>The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01166</drugbank-id>
      <name>Cilostazol</name>
      <description>The risk or severity of bleeding can be increased when Cilostazol is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01207</drugbank-id>
      <name>Ridogrel</name>
      <description>The risk or severity of bleeding can be increased when Ridogrel is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01236</drugbank-id>
      <name>Sevoflurane</name>
      <description>The risk or severity of bleeding can be increased when Sevoflurane is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02709</drugbank-id>
      <name>Resveratrol</name>
      <description>The risk or severity of bleeding can be increased when Resveratrol is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04743</drugbank-id>
      <name>Nimesulide</name>
      <description>The risk or severity of bleeding can be increased when Nimesulide is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04905</drugbank-id>
      <name>Tesmilifene</name>
      <description>The risk or severity of bleeding can be increased when Tesmilifene is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05266</drugbank-id>
      <name>Ibudilast</name>
      <description>The risk or severity of bleeding can be increased when Ibudilast is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05767</drugbank-id>
      <name>Andrographolide</name>
      <description>The risk or severity of bleeding can be increased when Andrographolide is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06081</drugbank-id>
      <name>Caplacizumab</name>
      <description>The risk or severity of bleeding can be increased when Caplacizumab is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB07615</drugbank-id>
      <name>Tranilast</name>
      <description>The risk or severity of bleeding can be increased when Tranilast is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08887</drugbank-id>
      <name>Icosapent ethyl</name>
      <description>The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09283</drugbank-id>
      <name>Trapidil</name>
      <description>The risk or severity of bleeding can be increased when Trapidil is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12092</drugbank-id>
      <name>Naftopidil</name>
      <description>The risk or severity of bleeding can be increased when Naftopidil is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12163</drugbank-id>
      <name>Sarpogrelate</name>
      <description>The risk or severity of bleeding can be increased when Sarpogrelate is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12321</drugbank-id>
      <name>Ifetroban</name>
      <description>The risk or severity of bleeding can be increased when Ifetroban is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12445</drugbank-id>
      <name>Nitroaspirin</name>
      <description>The risk or severity of bleeding can be increased when Nitroaspirin is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12465</drugbank-id>
      <name>Ketanserin</name>
      <description>The risk or severity of bleeding can be increased when Ketanserin is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12545</drugbank-id>
      <name>Indobufen</name>
      <description>The risk or severity of bleeding can be increased when Indobufen is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12749</drugbank-id>
      <name>Butylphthalide</name>
      <description>The risk or severity of bleeding can be increased when Butylphthalide is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12771</drugbank-id>
      <name>Hydroxytyrosol</name>
      <description>The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13036</drugbank-id>
      <name>Ramatroban</name>
      <description>The risk or severity of bleeding can be increased when Ramatroban is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13327</drugbank-id>
      <name>Picotamide</name>
      <description>The risk or severity of bleeding can be increased when Picotamide is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13367</drugbank-id>
      <name>Cloricromen</name>
      <description>The risk or severity of bleeding can be increased when Cloricromen is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13400</drugbank-id>
      <name>Linsidomine</name>
      <description>The risk or severity of bleeding can be increased when Linsidomine is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13510</drugbank-id>
      <name>Buflomedil</name>
      <description>The risk or severity of bleeding can be increased when Buflomedil is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13929</drugbank-id>
      <name>Relcovaptan</name>
      <description>The risk or severity of bleeding can be increased when Relcovaptan is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10076</drugbank-id>
      <name>Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen</name>
      <description>The risk or severity of adverse effects can be increased when Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10342</drugbank-id>
      <name>Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen</name>
      <description>The risk or severity of adverse effects can be increased when Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10600</drugbank-id>
      <name>Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated)</name>
      <description>The risk or severity of adverse effects can be increased when Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10794</drugbank-id>
      <name>Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated)</name>
      <description>The risk or severity of adverse effects can be increased when Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10990</drugbank-id>
      <name>Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen</name>
      <description>The risk or severity of adverse effects can be increased when Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11038</drugbank-id>
      <name>Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated)</name>
      <description>The risk or severity of adverse effects can be increased when Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11040</drugbank-id>
      <name>Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated)</name>
      <description>The risk or severity of adverse effects can be increased when Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11041</drugbank-id>
      <name>Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)</name>
      <description>The risk or severity of adverse effects can be increased when Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11044</drugbank-id>
      <name>Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated)</name>
      <description>The risk or severity of adverse effects can be increased when Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14384</drugbank-id>
      <name>Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated)</name>
      <description>The risk or severity of adverse effects can be increased when Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14385</drugbank-id>
      <name>Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated)</name>
      <description>The risk or severity of adverse effects can be increased when Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14394</drugbank-id>
      <name>Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen</name>
      <description>The risk or severity of adverse effects can be increased when Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14445</drugbank-id>
      <name>Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated)</name>
      <description>The risk or severity of adverse effects can be increased when Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14449</drugbank-id>
      <name>Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen</name>
      <description>The risk or severity of adverse effects can be increased when Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14619</drugbank-id>
      <name>Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated)</name>
      <description>The risk or severity of adverse effects can be increased when Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14620</drugbank-id>
      <name>Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated)</name>
      <description>The risk or severity of adverse effects can be increased when Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09413</drugbank-id>
      <name>Monopotassium phosphate</name>
      <description>The serum concentration of Bismuth subsalicylate can be increased when it is combined with Monopotassium phosphate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10318</drugbank-id>
      <name>Varicella Zoster Vaccine (Live/attenuated)</name>
      <description>The risk or severity of adverse effects can be increased when Bismuth subsalicylate is combined with Varicella Zoster Vaccine (Live/attenuated).</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00024</drugbank-id>
      <name>Thyrotropin alfa</name>
      <description>The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00279</drugbank-id>
      <name>Liothyronine</name>
      <description>The therapeutic efficacy of Liothyronine can be increased when used in combination with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00451</drugbank-id>
      <name>Levothyroxine</name>
      <description>The therapeutic efficacy of Levothyroxine can be increased when used in combination with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01583</drugbank-id>
      <name>Liotrix</name>
      <description>The therapeutic efficacy of Liotrix can be increased when used in combination with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB03604</drugbank-id>
      <name>Tiratricol</name>
      <description>The therapeutic efficacy of Tiratricol can be increased when used in combination with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09100</drugbank-id>
      <name>Thyroid, porcine</name>
      <description>The therapeutic efficacy of Thyroid, porcine can be increased when used in combination with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00316</drugbank-id>
      <name>Acetaminophen</name>
      <description>The risk or severity of adverse effects can be increased when Acetaminophen is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09288</drugbank-id>
      <name>Propacetamol</name>
      <description>The risk or severity of adverse effects can be increased when Propacetamol is combined with Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00695</drugbank-id>
      <name>Furosemide</name>
      <description>The risk or severity of adverse effects can be increased when Bismuth subsalicylate is combined with Furosemide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00030</drugbank-id>
      <name>Insulin human</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Insulin human.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00046</drugbank-id>
      <name>Insulin lispro</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Insulin lispro.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00047</drugbank-id>
      <name>Insulin glargine</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Insulin glargine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00071</drugbank-id>
      <name>Insulin pork</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Insulin pork.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00197</drugbank-id>
      <name>Troglitazone</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Troglitazone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00222</drugbank-id>
      <name>Glimepiride</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Glimepiride.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00263</drugbank-id>
      <name>Sulfisoxazole</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Sulfisoxazole.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00280</drugbank-id>
      <name>Disopyramide</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Disopyramide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00284</drugbank-id>
      <name>Acarbose</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Acarbose.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00331</drugbank-id>
      <name>Metformin</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Metformin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00359</drugbank-id>
      <name>Sulfadiazine</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Sulfadiazine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00412</drugbank-id>
      <name>Rosiglitazone</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Rosiglitazone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00414</drugbank-id>
      <name>Acetohexamide</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Acetohexamide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00468</drugbank-id>
      <name>Quinine</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Quinine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00491</drugbank-id>
      <name>Miglitol</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Miglitol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00672</drugbank-id>
      <name>Chlorpropamide</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Chlorpropamide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00731</drugbank-id>
      <name>Nateglinide</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Nateglinide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00738</drugbank-id>
      <name>Pentamidine</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Pentamidine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00834</drugbank-id>
      <name>Mifepristone</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Mifepristone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00839</drugbank-id>
      <name>Tolazamide</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Tolazamide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00912</drugbank-id>
      <name>Repaglinide</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Repaglinide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00914</drugbank-id>
      <name>Phenformin</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Phenformin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01015</drugbank-id>
      <name>Sulfamethoxazole</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Sulfamethoxazole.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01016</drugbank-id>
      <name>Glyburide</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Glyburide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01067</drugbank-id>
      <name>Glipizide</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Glipizide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01120</drugbank-id>
      <name>Gliclazide</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Gliclazide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01124</drugbank-id>
      <name>Tolbutamide</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Tolbutamide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01132</drugbank-id>
      <name>Pioglitazone</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Pioglitazone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01200</drugbank-id>
      <name>Bromocriptine</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Bromocriptine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01251</drugbank-id>
      <name>Gliquidone</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Gliquidone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01252</drugbank-id>
      <name>Mitiglinide</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Mitiglinide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01261</drugbank-id>
      <name>Sitagliptin</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Sitagliptin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01268</drugbank-id>
      <name>Sunitinib</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Sunitinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01276</drugbank-id>
      <name>Exenatide</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Exenatide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01277</drugbank-id>
      <name>Mecasermin</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Mecasermin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01278</drugbank-id>
      <name>Pramlintide</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Pramlintide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01289</drugbank-id>
      <name>Glisoxepide</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Glisoxepide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01306</drugbank-id>
      <name>Insulin aspart</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Insulin aspart.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01307</drugbank-id>
      <name>Insulin detemir</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Insulin detemir.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01309</drugbank-id>
      <name>Insulin glulisine</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Insulin glulisine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01382</drugbank-id>
      <name>Glymidine</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Glymidine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01700</drugbank-id>
      <name>AICA ribonucleotide</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of AICA ribonucleotide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04830</drugbank-id>
      <name>Buformin</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Buformin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04876</drugbank-id>
      <name>Vildagliptin</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Vildagliptin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04878</drugbank-id>
      <name>Voglibose</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Voglibose.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05115</drugbank-id>
      <name>NN344</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of NN344.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05819</drugbank-id>
      <name>NBI-6024</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of NBI-6024.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06011</drugbank-id>
      <name>AMG-222</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of AMG-222.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06127</drugbank-id>
      <name>Bisegliptin</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Bisegliptin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06203</drugbank-id>
      <name>Alogliptin</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Alogliptin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06292</drugbank-id>
      <name>Dapagliflozin</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Dapagliflozin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06335</drugbank-id>
      <name>Saxagliptin</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Saxagliptin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06655</drugbank-id>
      <name>Liraglutide</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Liraglutide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08382</drugbank-id>
      <name>Gosogliptin</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Gosogliptin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08882</drugbank-id>
      <name>Linagliptin</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Linagliptin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08907</drugbank-id>
      <name>Canagliflozin</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Canagliflozin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08962</drugbank-id>
      <name>Glibornuride</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Glibornuride.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09022</drugbank-id>
      <name>Benfluorex</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Benfluorex.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09038</drugbank-id>
      <name>Empagliflozin</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Empagliflozin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09043</drugbank-id>
      <name>Albiglutide</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Albiglutide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09045</drugbank-id>
      <name>Dulaglutide</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Dulaglutide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09198</drugbank-id>
      <name>Lobeglitazone</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Lobeglitazone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09199</drugbank-id>
      <name>Netoglitazone</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Netoglitazone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09200</drugbank-id>
      <name>Rivoglitazone</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Rivoglitazone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09201</drugbank-id>
      <name>Ciglitazone</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Ciglitazone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09265</drugbank-id>
      <name>Lixisenatide</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Lixisenatide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09456</drugbank-id>
      <name>Insulin beef</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Insulin beef.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09564</drugbank-id>
      <name>Insulin degludec</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Insulin degludec.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11567</drugbank-id>
      <name>Insulin peglispro</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Insulin peglispro.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11568</drugbank-id>
      <name>Insulin tregopil</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Insulin tregopil.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11698</drugbank-id>
      <name>Ipragliflozin</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Ipragliflozin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11723</drugbank-id>
      <name>Dutogliptin</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Dutogliptin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11780</drugbank-id>
      <name>Allicin</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Allicin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11824</drugbank-id>
      <name>Tofogliflozin</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Tofogliflozin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11827</drugbank-id>
      <name>Ertugliflozin</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Ertugliflozin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11898</drugbank-id>
      <name>2,4-thiazolidinedione</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of 2,4-thiazolidinedione.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11936</drugbank-id>
      <name>Bempedoic acid</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Bempedoic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11950</drugbank-id>
      <name>Teneligliptin</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Teneligliptin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11992</drugbank-id>
      <name>Omarigliptin</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Omarigliptin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12268</drugbank-id>
      <name>Carmegliptin</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Carmegliptin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12412</drugbank-id>
      <name>Gemigliptin</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Gemigliptin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12417</drugbank-id>
      <name>Anagliptin</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Anagliptin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12625</drugbank-id>
      <name>Evogliptin</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Evogliptin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12713</drugbank-id>
      <name>Sotagliflozin</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Sotagliflozin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12781</drugbank-id>
      <name>Balaglitazone</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Balaglitazone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12935</drugbank-id>
      <name>Remogliflozin etabonate</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Remogliflozin etabonate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13406</drugbank-id>
      <name>Carbutamide</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Carbutamide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13446</drugbank-id>
      <name>Guar gum</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Guar gum.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13675</drugbank-id>
      <name>Metahexamide</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Metahexamide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13928</drugbank-id>
      <name>Semaglutide</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Semaglutide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14027</drugbank-id>
      <name>Taspoglutide</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Taspoglutide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14035</drugbank-id>
      <name>Englitazone</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Englitazone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15171</drugbank-id>
      <name>Tirzepatide</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Tirzepatide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB15217</drugbank-id>
      <name>Gastric inhibitory polypeptide</name>
      <description>Bismuth subsalicylate may increase the hypoglycemic activities of Gastric inhibitory polypeptide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00091</drugbank-id>
      <name>Cyclosporine</name>
      <description>Cyclosporine may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00202</drugbank-id>
      <name>Succinylcholine</name>
      <description>Succinylcholine may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00206</drugbank-id>
      <name>Reserpine</name>
      <description>Reserpine may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00246</drugbank-id>
      <name>Ziprasidone</name>
      <description>Ziprasidone may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00260</drugbank-id>
      <name>Cycloserine</name>
      <description>Cycloserine may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00321</drugbank-id>
      <name>Amitriptyline</name>
      <description>Amitriptyline may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00344</drugbank-id>
      <name>Protriptyline</name>
      <description>Protriptyline may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00361</drugbank-id>
      <name>Vinorelbine</name>
      <description>Vinorelbine may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00363</drugbank-id>
      <name>Clozapine</name>
      <description>Clozapine may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00372</drugbank-id>
      <name>Thiethylperazine</name>
      <description>Thiethylperazine may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00391</drugbank-id>
      <name>Sulpiride</name>
      <description>Sulpiride may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00408</drugbank-id>
      <name>Loxapine</name>
      <description>Loxapine may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00409</drugbank-id>
      <name>Remoxipride</name>
      <description>Remoxipride may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00420</drugbank-id>
      <name>Promazine</name>
      <description>Promazine may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00433</drugbank-id>
      <name>Prochlorperazine</name>
      <description>Prochlorperazine may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00444</drugbank-id>
      <name>Teniposide</name>
      <description>Teniposide may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00450</drugbank-id>
      <name>Droperidol</name>
      <description>Droperidol may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00458</drugbank-id>
      <name>Imipramine</name>
      <description>Imipramine may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00477</drugbank-id>
      <name>Chlorpromazine</name>
      <description>Chlorpromazine may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00502</drugbank-id>
      <name>Haloperidol</name>
      <description>Haloperidol may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00508</drugbank-id>
      <name>Triflupromazine</name>
      <description>Triflupromazine may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00531</drugbank-id>
      <name>Cyclophosphamide</name>
      <description>Cyclophosphamide may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00540</drugbank-id>
      <name>Nortriptyline</name>
      <description>Nortriptyline may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00541</drugbank-id>
      <name>Vincristine</name>
      <description>Vincristine may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00543</drugbank-id>
      <name>Amoxapine</name>
      <description>Amoxapine may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00623</drugbank-id>
      <name>Fluphenazine</name>
      <description>Fluphenazine may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00649</drugbank-id>
      <name>Stavudine</name>
      <description>Stavudine may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00679</drugbank-id>
      <name>Thioridazine</name>
      <description>Thioridazine may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00680</drugbank-id>
      <name>Moricizine</name>
      <description>Moricizine may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00726</drugbank-id>
      <name>Trimipramine</name>
      <description>Trimipramine may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00734</drugbank-id>
      <name>Risperidone</name>
      <description>Risperidone may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00831</drugbank-id>
      <name>Trifluoperazine</name>
      <description>Trifluoperazine may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00850</drugbank-id>
      <name>Perphenazine</name>
      <description>Perphenazine may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00875</drugbank-id>
      <name>Flupentixol</name>
      <description>Flupentixol may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00898</drugbank-id>
      <name>Ethanol</name>
      <description>Ethanol may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00900</drugbank-id>
      <name>Didanosine</name>
      <description>Didanosine may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00924</drugbank-id>
      <name>Cyclobenzaprine</name>
      <description>Cyclobenzaprine may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00933</drugbank-id>
      <name>Mesoridazine</name>
      <description>Mesoridazine may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01063</drugbank-id>
      <name>Acetophenazine</name>
      <description>Acetophenazine may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01069</drugbank-id>
      <name>Promethazine</name>
      <description>Promethazine may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01100</drugbank-id>
      <name>Pimozide</name>
      <description>Pimozide may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01142</drugbank-id>
      <name>Doxepin</name>
      <description>Doxepin may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01151</drugbank-id>
      <name>Desipramine</name>
      <description>Desipramine may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01190</drugbank-id>
      <name>Clindamycin</name>
      <description>Clindamycin may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01199</drugbank-id>
      <name>Tubocurarine</name>
      <description>Tubocurarine may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01229</drugbank-id>
      <name>Paclitaxel</name>
      <description>Paclitaxel may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01238</drugbank-id>
      <name>Aripiprazole</name>
      <description>Aripiprazole may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01239</drugbank-id>
      <name>Chlorprothixene</name>
      <description>Chlorprothixene may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01242</drugbank-id>
      <name>Clomipramine</name>
      <description>Clomipramine may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01245</drugbank-id>
      <name>Decamethonium</name>
      <description>Decamethonium may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01246</drugbank-id>
      <name>Alimemazine</name>
      <description>Alimemazine may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01267</drugbank-id>
      <name>Paliperidone</name>
      <description>Paliperidone may increase the neurotoxic activities of Bismuth subsalicylate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01356</drugbank-id>
      <name>Lithium cation</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Lithium cation.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01403</drugbank-id>
      <name>Methotrimeprazine</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Methotrimeprazine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01598</drugbank-id>
      <name>Imipenem</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Imipenem.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01608</drugbank-id>
      <name>Periciazine</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Periciazine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01614</drugbank-id>
      <name>Acepromazine</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Acepromazine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01615</drugbank-id>
      <name>Aceprometazine</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Aceprometazine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01618</drugbank-id>
      <name>Molindone</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Molindone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01621</drugbank-id>
      <name>Pipotiazine</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Pipotiazine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01622</drugbank-id>
      <name>Thioproperazine</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Thioproperazine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01623</drugbank-id>
      <name>Thiothixene</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Thiothixene.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01624</drugbank-id>
      <name>Zuclopenthixol</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Zuclopenthixol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01627</drugbank-id>
      <name>Lincomycin</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Lincomycin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04836</drugbank-id>
      <name>Amineptine</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Amineptine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04872</drugbank-id>
      <name>Osanetant</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Osanetant.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04888</drugbank-id>
      <name>Bifeprunox</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Bifeprunox.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04946</drugbank-id>
      <name>Iloperidone</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Iloperidone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05316</drugbank-id>
      <name>Pimavanserin</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Pimavanserin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05687</drugbank-id>
      <name>BL-1020</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of BL-1020.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06016</drugbank-id>
      <name>Cariprazine</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Cariprazine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06144</drugbank-id>
      <name>Sertindole</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Sertindole.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06216</drugbank-id>
      <name>Asenapine</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Asenapine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06288</drugbank-id>
      <name>Amisulpride</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Amisulpride.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08815</drugbank-id>
      <name>Lurasidone</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Lurasidone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08922</drugbank-id>
      <name>Perospirone</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Perospirone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08927</drugbank-id>
      <name>Amperozide</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Amperozide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08996</drugbank-id>
      <name>Dimetacrine</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Dimetacrine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09000</drugbank-id>
      <name>Cyamemazine</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Cyamemazine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09016</drugbank-id>
      <name>Butriptyline</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Butriptyline.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09128</drugbank-id>
      <name>Brexpiprazole</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Brexpiprazole.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09167</drugbank-id>
      <name>Dosulepin</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Dosulepin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09223</drugbank-id>
      <name>Blonanserin</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Blonanserin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09224</drugbank-id>
      <name>Melperone</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Melperone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09225</drugbank-id>
      <name>Zotepine</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Zotepine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09226</drugbank-id>
      <name>RP-5063</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of RP-5063.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09241</drugbank-id>
      <name>Methylene blue</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Methylene blue.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09286</drugbank-id>
      <name>Pipamperone</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Pipamperone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09289</drugbank-id>
      <name>Tianeptine</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Tianeptine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09307</drugbank-id>
      <name>Oxaprotiline</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Oxaprotiline.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11376</drugbank-id>
      <name>Azaperone</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Azaperone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11537</drugbank-id>
      <name>Pirlimycin</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Pirlimycin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11540</drugbank-id>
      <name>Propiopromazine</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Propiopromazine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12273</drugbank-id>
      <name>Ecopipam</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Ecopipam.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12401</drugbank-id>
      <name>Bromperidol</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Bromperidol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12518</drugbank-id>
      <name>Raclopride</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Raclopride.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12693</drugbank-id>
      <name>Ritanserin</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Ritanserin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12710</drugbank-id>
      <name>Perazine</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Perazine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12867</drugbank-id>
      <name>Benperidol</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Benperidol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12930</drugbank-id>
      <name>Opipramol</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Opipramol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12958</drugbank-id>
      <name>Prothipendyl</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Prothipendyl.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13025</drugbank-id>
      <name>Tiapride</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Tiapride.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13114</drugbank-id>
      <name>Amitriptylinoxide</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Amitriptylinoxide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13213</drugbank-id>
      <name>Butaperazine</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Butaperazine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13225</drugbank-id>
      <name>Dibenzepin</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Dibenzepin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13246</drugbank-id>
      <name>Quinupramine</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Quinupramine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13256</drugbank-id>
      <name>Clothiapine</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Clothiapine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13273</drugbank-id>
      <name>Sultopride</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Sultopride.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13382</drugbank-id>
      <name>Chlorproethazine</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Chlorproethazine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13384</drugbank-id>
      <name>Melitracen</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Melitracen.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13403</drugbank-id>
      <name>Oxypertine</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Oxypertine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13411</drugbank-id>
      <name>Lofepramine</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Lofepramine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13420</drugbank-id>
      <name>Thiazinam</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Thiazinam.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13496</drugbank-id>
      <name>Iprindole</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Iprindole.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13523</drugbank-id>
      <name>Veralipride</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Veralipride.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13552</drugbank-id>
      <name>Trifluperidol</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Trifluperidol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13554</drugbank-id>
      <name>Moperone</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Moperone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13557</drugbank-id>
      <name>Thiopropazate</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Thiopropazate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13584</drugbank-id>
      <name>Gallamine</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Gallamine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13598</drugbank-id>
      <name>Diethyl ether</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Diethyl ether.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13665</drugbank-id>
      <name>Fluanisone</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Fluanisone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13676</drugbank-id>
      <name>Mosapramine</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Mosapramine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13782</drugbank-id>
      <name>Imipramine oxide</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Imipramine oxide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13784</drugbank-id>
      <name>Dixyrazine</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Dixyrazine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13841</drugbank-id>
      <name>Clopenthixol</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Clopenthixol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14185</drugbank-id>
      <name>Aripiprazole lauroxil</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Aripiprazole lauroxil.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14651</drugbank-id>
      <name>Perphenazine enanthate</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Perphenazine enanthate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00781</drugbank-id>
      <name>Polymyxin B</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Polymyxin B.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04842</drugbank-id>
      <name>Fluspirilene</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Fluspirilene.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12093</drugbank-id>
      <name>Tetrahydropalmatine</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Tetrahydropalmatine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13791</drugbank-id>
      <name>Penfluridol</name>
      <description>Bismuth subsalicylate may increase the neurotoxic activities of Penfluridol.</description>
    </drug-interaction>
  </drug-interactions>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>0.37</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-0.78</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>5.97e+01 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>1.11</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>2-hydroxy-2H,4H-benzo[d]1,3-dioxa-2-bismacyclohexan-4-one</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>atovaquone</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>362.0926</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>361.999166889</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>O[Bi]1OC(=O)C2=CC=CC=C2O1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C7H5BiO4</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C7H6O3.Bi.H2O/c8-6-4-2-1-3-5(6)7(9)10;;/h1-4,8H,(H,9,10);;1H2/q;+3;/p-3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>ZREIPSZUJIFJNP-UHFFFAOYSA-K</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>55.76</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>35.72</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>15.66</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>14.3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest basic)</kind>
      <value>-3.1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties/>
  <external-identifiers>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>6404</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>261649</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>16682734</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>46507128</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Compound</resource>
      <identifier>C07870</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Drug</resource>
      <identifier>D00728</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>17215772</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PharmGKB</resource>
      <identifier>PA164774805</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Bismuth_subsalicylate</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL1120</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links>
    <external-link>
      <resource>RxList</resource>
      <url>http://www.rxlist.com/cgi/generic/pylera.htm</url>
    </external-link>
    <external-link>
      <resource>Drugs.com</resource>
      <url>http://www.drugs.com/cdi/bismuth-subsalicylate.html</url>
    </external-link>
  </external-links>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets/>
  <enzymes/>
  <carriers>
    <carrier position="1">
      <id>BE0000530</id>
      <name>Serum albumin</name>
      <organism>Humans</organism>
      <actions>
        <action>binder</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A16835</ref-id>
            <pubmed-id>11110794</pubmed-id>
            <citation>Sun H, Li H, Mason AB, Woodworth RC, Sadler PJ: Competitive binding of bismuth to transferrin and albumin in aqueous solution and in blood plasma. J Biol Chem. 2001 Mar 23;276(12):8829-35. Epub 2000 Dec 7.</citation>
          </article>
          <article>
            <ref-id>A16836</ref-id>
            <pubmed-id>12620681</pubmed-id>
            <citation>Sun H, Szeto KY: Binding of bismuth to serum proteins: implication for targets of Bi(III) in blood plasma. J Inorg Biochem. 2003 Feb 1;94(1-2):114-20.</citation>
          </article>
          <article>
            <ref-id>A9</ref-id>
            <pubmed-id>11752352</pubmed-id>
            <citation>Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P02768" source="Swiss-Prot">
        <name>Serum albumin</name>
        <general-function>Toxic substance binding</general-function>
        <specific-function>Serum albumin, the main protein of plasma, has a good binding capacity for water, Ca(2+), Na(+), K(+), fatty acids, hormones, bilirubin and drugs. Its main function is the regulation of the colloidal osmotic pressure of blood. Major zinc transporter in plasma, typically binds about 80% of all plasma zinc.</specific-function>
        <gene-name>ALB</gene-name>
        <locus>4q11-q13</locus>
        <cellular-location>Secreted</cellular-location>
        <transmembrane-regions/>
        <signal-regions>1-18</signal-regions>
        <theoretical-pi>6.21</theoretical-pi>
        <molecular-weight>69365.94</molecular-weight>
        <chromosome-location>4</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:399</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>ALB</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>V00494</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>28590</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P02768</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>ALBU_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>Serum albumin precursor</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001058|Serum albumin
MKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPF
EDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEP
ERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLF
FAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAV
ARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLK
ECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYAR
RHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFE
QLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVV
LNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTL
SEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLV
AASQAALGL</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0010372|Serum albumin (ALB)
ATGAAGTGGGTAACCTTTATTTCCCTTCTTTTTCTCTTTAGCTCGGCTTATTCCAGGGGT
GTGTTTCGTCGAGATGCACACAAGAGTGAGGTTGCTCATCGGTTTAAAGATTTGGGAGAA
GAAAATTTCAAAGCCTTGGTGTTGATTGCCTTTGCTCAGTATCTTCAGCAGTGTCCATTT
GAAGATCATGTAAAATTAGTGAATGAAGTAACTGAATTTGCAAAAACATGTGTTGCTGAT
GAGTCAGCTGAAAATTGTGACAAATCACTTCATACCCTTTTTGGAGACAAATTATGCACA
GTTGCAACTCTTCGTGAAACCTATGGTGAAATGGCTGACTGCTGTGCAAAACAAGAACCT
GAGAGAAATGAATGCTTCTTGCAACACAAAGATGACAACCCAAACCTCCCCCGATTGGTG
AGACCAGAGGTTGATGTGATGTGCACTGCTTTTCATGACAATGAAGAGACATTTTTGAAA
AAATACTTATATGAAATTGCCAGAAGACATCCTTACTTTTATGCCCCGGAACTCCTTTTC
TTTGCTAAAAGGTATAAAGCTGCTTTTACAGAATGTTGCCAAGCTGCTGATAAAGCTGCC
TGCCTGTTGCCAAAGCTCGATGAACTTCGGGATGAAGGGAAGGCTTCGTCTGCCAAACAG
AGACTCAAGTGTGCCAGTCTCCAAAAATTTGGAGAAAGAGCTTTCAAAGCATGGGCAGTA
GCTCGCCTGAGCCAGAGATTTCCCAAAGCTGAGTTTGCAGAAGTTTCCAAGTTAGTGACA
GATCTTACCAAAGTCCACACGGAATGCTGCCATGGAGATCTGCTTGAATGTGCTGATGAC
AGGGCGGACCTTGCCAAGTATATCTGTGAAAATCAAGATTCGATCTCCAGTAAACTGAAG
GAATGCTGTGAAAAACCTCTGTTGGAAAAATCCCACTGCATTGCCGAAGTGGAAAATGAT
GAGATGCCTGCTGACTTGCCTTCATTAGCTGCTGATTTTGTTGAAAGTAAGGATGTTTGC
AAAAACTATGCTGAGGCAAAGGATGTCTTCCTGGGCATGTTTTTGTATGAATATGCAAGA
AGGCATCCTGATTACTCTGTCGTGCTGCTGCTGAGACTTGCCAAGACATATGAAACCACT
CTAGAGAAGTGCTGTGCCGCTGCAGATCCTCATGAATGCTATGCCAAAGTGTTCGATGAA
TTTAAACCTCTTGTGGAAGAGCCTCAGAATTTAATCAAACAAAATTGTGAGCTTTTTGAG
CAGCTTGGAGAGTACAAATTCCAGAATGCGCTATTAGTTCGTTACACCAAGAAAGTACCC
CAAGTGTCAACTCCAACTCTTGTAGAGGTCTCAAGAAACCTAGGAAAAGTGGGCAGCAAA
TGTTGTAAACATCCTGAAGCAAAAAGAATGCCCTGTGCAGAAGACTATCTATCCGTGGTC
CTGAACCAGTTATGTGTGTTGCATGAGAAAACGCCAGTAAGTGACAGAGTCACCAAATGC
TGCACAGAATCCTTGGTGAACAGGCGACCATGCTTTTCAGCTCTGGAAGTCGATGAAACA
TACGTTCCCAAAGAGTTTAATGCTGAAACATTCACCTTCCATGCAGATATATGCACACTT
TCTGAGAAGGAGAGACAAATCAAGAAACAAACTGCACTTGTTGAGCTCGTGAAACACAAG
CCCAAGGCAACAAAAGAGCAACTGAAAGCTGTTATGGATGATTTCGCAGCTTTTGTAGAG
AAGTGCTGCAAGGCTGACGATAAGGAGACCTGCTTTGCCGAGGAGGGTAAAAAACTTGTT
GCTGCAAGTCAAGCTGCCTTAGGCTTATAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00273</identifier>
            <name>Serum_albumin</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>blood microparticle</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>endoplasmic reticulum</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular exosome</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular region</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular space</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>Golgi apparatus</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>myelin sheath</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>nucleus</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>platelet alpha granule lumen</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>protein complex</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>antioxidant activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>chaperone binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>copper ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>DNA binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>drug binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>fatty acid binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>pyridoxal phosphate binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>toxic substance binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>bile acid and bile salt transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>bile acid metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>blood coagulation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular response to starvation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>hemolysis by symbiont of host erythrocytes</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>lipoprotein metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>maintenance of mitochondrion location</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of apoptotic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of programmed cell death</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>platelet activation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>platelet degranulation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>receptor-mediated endocytosis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>retina homeostasis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small molecule metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>sodium-independent organic anion transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>transmembrane transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>transport</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </carrier>
    <carrier position="2">
      <id>BE0000510</id>
      <name>Serotransferrin</name>
      <organism>Humans</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A16835</ref-id>
            <pubmed-id>11110794</pubmed-id>
            <citation>Sun H, Li H, Mason AB, Woodworth RC, Sadler PJ: Competitive binding of bismuth to transferrin and albumin in aqueous solution and in blood plasma. J Biol Chem. 2001 Mar 23;276(12):8829-35. Epub 2000 Dec 7.</citation>
          </article>
          <article>
            <ref-id>A16836</ref-id>
            <pubmed-id>12620681</pubmed-id>
            <citation>Sun H, Szeto KY: Binding of bismuth to serum proteins: implication for targets of Bi(III) in blood plasma. J Inorg Biochem. 2003 Feb 1;94(1-2):114-20.</citation>
          </article>
          <article>
            <ref-id>A16962</ref-id>
            <pubmed-id>15519234</pubmed-id>
            <citation>Zhang M, Gumerov DR, Kaltashov IA, Mason AB: Indirect detection of protein-metal binding: interaction of serum transferrin with In3+ and Bi3+. J Am Soc Mass Spectrom. 2004 Nov;15(11):1658-64.</citation>
          </article>
          <article>
            <ref-id>A16963</ref-id>
            <pubmed-id>15544343</pubmed-id>
            <citation>Miquel G, Nekaa T, Kahn PH, Hemadi M, El Hage Chahine JM: Mechanism of formation of the complex between transferrin and bismuth, and interaction with transferrin receptor 1. Biochemistry. 2004 Nov 23;43(46):14722-31.</citation>
          </article>
          <article>
            <ref-id>A16964</ref-id>
            <pubmed-id>17330963</pubmed-id>
            <citation>Ge R, Sun H: Bioinorganic chemistry of bismuth and antimony: target sites of metallodrugs. Acc Chem Res. 2007 Apr;40(4):267-74. Epub 2007 Mar 2.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P02787" source="Swiss-Prot">
        <name>Serotransferrin</name>
        <general-function>Transferrin receptor binding</general-function>
        <specific-function>Transferrins are iron binding transport proteins which can bind two Fe(3+) ions in association with the binding of an anion, usually bicarbonate. It is responsible for the transport of iron from sites of absorption and heme degradation to those of storage and utilization. Serum transferrin may also have a further role in stimulating cell proliferation.</specific-function>
        <gene-name>TF</gene-name>
        <locus>3q22.1</locus>
        <cellular-location>Secreted</cellular-location>
        <transmembrane-regions/>
        <signal-regions>1-19</signal-regions>
        <theoretical-pi>7.13</theoretical-pi>
        <molecular-weight>77063.195</molecular-weight>
        <chromosome-location>3</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:11740</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>TF</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>M12530</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>339453</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P02787</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>TRFE_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>Beta-1 metal-binding globulin</synonym>
          <synonym>Siderophilin</synonym>
          <synonym>Transferrin</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037031|Serotransferrin
MRLAVGALLVCAVLGLCLAVPDKTVRWCAVSEHEATKCQSFRDHMKSVIPSDGPSVACVK
KASYLDCIRAIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSKEDPQTFYYAVAVV
KKDSGFQMNQLRGKKSCHTGLGRSAGWNIPIGLLYCDLPEPRKPLEKAVANFFSGSCAPC
ADGTDFPQLCQLCPGCGCSTLNQYFGYSGAFKCLKDGAGDVAFVKHSTIFENLANKADRD
QYELLCLDNTRKPVDEYKDCHLAQVPSHTVVARSMGGKEDLIWELLNQAQEHFGKDKSKE
FQLFSSPHGKDLLFKDSAHGFLKVPPRMDAKMYLGYEYVTAIRNLREGTCPEAPTDECKP
VKWCALSHHERLKCDEWSVNSVGKIECVSAETTEDCIAKIMNGEADAMSLDGGFVYIAGK
CGLVPVLAENYNKSDNCEDTPEAGYFAIAVVKKSASDLTWDNLKGKKSCHTAVGRTAGWN
IPMGLLYNKINHCRFDEFFSEGCAPGSKKDSSLCKLCMGSGLNLCEPNNKEGYYGYTGAF
RCLVEKGDVAFVKHQTVPQNTGGKNPDPWAKNLNEKDYELLCLDGTRKPVEEYANCHLAR
APNHAVVTRKDKEACVHKILRQQQHLFGSNVTDCSGNFCLFRSETKDLLFRDDTVCLAKL
HDRNTYEKYLGEEYVKAVGNLRKCSTSSLLEACTFRRP</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0021268|Serotransferrin (TF)
ATGAGGCTCGCCGTGGGAGCCCTGCTGGTCTGCGCCGTCCTGGGGCTGTGTCTGGCTGTC
CCTGATAAAACTGTGAGATGGTGTGCAGTGTCGGAGCATGAGGCCACTAAGTGCCAGAGT
TTCCGCGACCATATGAAAAGCGTCATTCCATCCGATGGTCCCAGTGTTGCTTGTGTGAAG
AAAGCCTCCTACCTTGATTGCATCAGGGCCATTGCGGCAAACGAAGCGGATGCTGTGACA
CTGGATGCAGGTTTGGTGTATGATGCTTACCTGGCTCCCAATAACCTGAAGCCTGTGGTG
GCAGAGTTCTATGGGTCAAAAGAGGATCCACAGACTTTCTATTATGCTGTTGCTGTGGTG
AAGAAGGATAGTGGCTTCCAGATGAACCAGCTTCGAGGCAAGAAGTCCTGCCACACGGGT
CTAGGCAGGTCCGCTGGGTGGAACATCCCCATAGGCTTACTTTACTGTGACTTACCTGAG
CCACGTAAACCTCTTGAGAAAGCAGTGGCCAATTTCTTCTCGGGCAGCTGTGCCCCTTGT
GCGGATGGGACGGACTTCCCCCAGCTGTGTCAACTGTGTCCAGGGTGTGGCTGCTCCACC
CTTAACCAATACTTCGGCTACTCGGGAGCCTTCAAGTGTCTGAAGGATGGTGCTGGGGAT
GTGGCCTTTGTCAAGCACTCGACTATATTTGAGAACTTGGCAAACAAGGCTGACAGGGAC
CAGTATGAGCTGCTTTGCCTGGACAACACCCGGAAGCCGGTAGATGAATACAAGGACTGC
CACTTGGCCCAGGTCCCTTCTCATACCGTCGTGGCCCGAAGTATGGGCGGCAAGGAGGAC
TTGATCTGGGAGCTTCTCAACCAGGCCCAGGAACATTTTGGCAAAGACAAATCAAAAGAA
TTCCAACTATTCAGCTCTCCTCATGGGAAGGACCTGCTGTTTAAGGACTCTGCCCACGGG
TTTTTAAAAGTCCCCCCCAGGATGGATGCCAAGATGTACCTGGGCTATGAGTATGTCACT
GCCATCCGGAATCTACGGGAAGGCACATGCCCAGAAGCCCCAACAGATGAATGCAAGCCT
GTGAAGTGGTGTGCGCTGAGCCACCACGAGAGGCTCAAGTGTGATGAGTGGAGTGTTAAC
AGTGTAGGGAAAATAGAGTGTGTATCAGCAGAGACCACCGAAGACTGCATCGCCAAGATC
ATGAATGGAGAAGCTGATGCCATGAGCTTGGATGGAGGGTTTGTCTACATAGCGGGCAAG
TGTGGTCTGGTGCCTGTCTTGGCAGAAAACTACAATAAGAGCGATAATTGTGAGGATACA
CCAGAGGCAGGGTATTTTGCTGTAGCAGTGGTGAAGAAATCAGCTTCTGACCTCACCTGG
GACAATCTGAAAGGCAAGAAGTCCTGCCATACGGCAGTTGGCAGAACCGCTGGCTGGAAC
ATCCCCATGGGCCTGCTCTACAATAAGATCAACCACTGCAGATTTGATGAATTTTTCAGT
GAAGGTTGTGCCCCTGGGTCTAAGAAAGACTCCAGTCTCTGTAAGCTGTGTATGGGCTCA
GGCCTAAACCTGTGTGAACCCAACAACAAAGAGGGATACTACGGCTACACAGGCGCTTTC
AGGTGTCTGGTTGAGAAGGGAGATGTGGCCTTTGTGAAACACCAGACTGTCCCACAGAAC
ACTGGGGGAAAAAACCCTGATCCATGGGCTAAGAATCTGAATGAAAAAGACTATGAGTTG
CTGTGCCTTGATGGTACCAGGAAACCTGTGGAGGAGTATGCGAACTGCCACCTGGCCAGA
GCCCCGAATCACGCTGTGGTCACACGGAAAGATAAGGAAGCTTGCGTCCACAAGATATTA
CGTCAACAGCAGCACCTATTTGGAAGCAACGTAACTGACTGCTCGGGCAACTTTTGTTTG
TTCCGGTCGGAAACCAAGGACCTTCTGTTCAGAGATGACACAGTATGTTTGGCCAAACTT
CATGACAGAAACACATATGAAAAATACTTAGGAGAAGAATATGTCAAGGCTGTTGGTAAC
CTGAGAAAATGCTCCACCTCATCACTCCTGGAAGCCTGCACTTTCCGTAGACCTTAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00405</identifier>
            <name>Transferrin</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>apical plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>basal part of cell</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>basal plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>blood microparticle</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>cell surface</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>coated pit</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>cytoplasmic membrane-bounded vesicle</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>early endosome</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>endocytic vesicle</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>endosome membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular exosome</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular region</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular space</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extrinsic component of external side of plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>HFE-transferrin receptor complex</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>late endosome</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>perinuclear region of cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>recycling endosome</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>secretory granule lumen</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>vesicle</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>ferric iron binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>ferric iron transmembrane transporter activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>ferrous iron binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>transferrin receptor binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>blood coagulation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular iron ion homeostasis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular response to iron ion</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>ferrous iron import into cell</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>iron ion homeostasis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>platelet activation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>platelet degranulation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of receptor-mediated endocytosis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of protein stability</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>retina homeostasis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>transferrin transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>transmembrane transport</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </carrier>
  </carriers>
  <transporters/>
</drug>